{"id":39181,"date":"2021-11-05T11:44:23","date_gmt":"2021-11-05T10:44:23","guid":{"rendered":"https:\/\/www.crct-inserm.fr\/v2\/?page_id=39181"},"modified":"2024-01-08T11:49:44","modified_gmt":"2024-01-08T10:49:44","slug":"t2i","status":"publish","type":"page","link":"https:\/\/www.crct-inserm.fr\/t2i\/","title":{"rendered":"T2i"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”a00720d8-8e3f-4b20-83b7-6d54485f541c” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”694d3d5d-3e0a-4cd1-b2ba-4eea0d99d5b4″ background_image=”https:\/\/www.crct-inserm.fr\/wp-content\/uploads\/2021\/11\/Maha_allCells_20190729_TSNE.png” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”8292df69-9d3c-4423-ab4f-a4755f6c1135″ width_tablet=”85%” width_phone=”95%” width_last_edited=”on|phone” custom_padding_last_edited=”off|desktop” global_colors_info=”{}”]<\/p>\n

\u00c9quipe
\nmaha ayyoub<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ header_2_font=”Open Sans||||||||” global_colors_info=”{}”]<\/p>\n

T2i : <\/strong><\/h2>\n

Immunit\u00e9 anti-tumorale et immunoth\u00e9rapie<\/strong><\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ disabled_on=”on|on|on” _builder_version=”4.16″ _module_preset=”default” width=”50%” disabled=”on” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.crct-inserm.fr\/wp-content\/uploads\/2021\/03\/LOGO-TOUCAN-Horizontal.png” title_text=”LOGO-TOUCAN-Horizontal” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font_size=”22px” global_colors_info=”{}”]Le laboratoire d\u2019Excellence Toulouse Cancer est un projet qui vise \u00e0 comprendre les m\u00e9canismes de r\u00e9sistance et de rechute dans les cancers.
\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”on|on|on” _builder_version=”4.16″ _module_preset=”default” use_background_color_gradient=”on” background_color_gradient_stops=”rgba(43,135,218,0) 50%|#f2efef 50%” background_color_gradient_start=”rgba(43,135,218,0)” background_color_gradient_start_position=”50%” background_color_gradient_end=”#f2efef” background_color_gradient_end_position=”0%” custom_padding=”0px|||||” disabled=”on” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px||0px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=FkQuawiGWUw” image_src=”https:\/\/www.crct-inserm.fr\/wp-content\/uploads\/2021\/03\/video.jpg” _builder_version=”4.16″ _module_preset=”default” width=”80%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” background_color=”#f2efef” custom_padding=”0px||0px|||” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

Les sp\u00e9cificit\u00e9s<\/strong><\/h2>\n

de notre axe de recherche<\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]Lymphocytes T sp\u00e9cifique des antig\u00e8nes tumoraux
\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”5px||0px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]\u00c9puisement des lymphocytes T
\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]Immunoth\u00e9rapie par inhibiteurs des points de contr\u00f4le immunitaire
\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]Vaccins anti-cancer
\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]Essais cliniques
\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]Mod\u00e8les pr\u00e9cliniques orthotopiques
\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]G\u00e9nomique
\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]Trancriptomique
\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

DES PROJETS<\/strong>
\nDE RECHERCHE<\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row use_custom_gutter=”on” gutter_width=”2″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”||0px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_blog fullwidth=”off” include_categories=”337″ use_manual_excerpt=”off” show_more=”on” show_author=”off” show_date=”off” show_categories=”off” masonry_tile_background_color=”#f2efef” _builder_version=”4.16″ _module_preset=”default” header_font=”|800|||||||” header_font_size=”20px” body_font_size=”20px” read_more_text_color=”#5EC7ED” read_more_font_size=”20px” read_more_line_height=”3em” background_enable_color=”off” border_width_all=”0px” global_colors_info=”{}”][\/et_pb_blog][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” custom_padding=”||0px|||” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

LES FOCUS<\/strong>
\nDE L\u2019\u00c9QUIPE<\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” use_background_color_gradient=”on” background_color_gradient_stops=”#ffffff 50%|rgba(174,227,246,0) 50%” background_color_gradient_overlays_image=”on” background_color_gradient_start=”#ffffff” background_color_gradient_start_position=”50%” background_color_gradient_end=”rgba(174,227,246,0)” background_color_gradient_end_position=”0%” background_image=”https:\/\/www.crct-inserm.fr\/wp-content\/uploads\/2021\/03\/Filets-bleu-actu.png” background_size=”contain” background_position=”bottom_center” custom_padding=”0px|||||” saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”4ae3b26e-eab0-4b6f-bd7b-05f173fca79b” custom_margin=”||-4px||false|false” header_font_size_tablet=”” header_font_size_phone=”” header_font_size_last_edited=”on|desktop” header_2_font_size_tablet=”” header_2_font_size_phone=”” header_2_font_size_last_edited=”on|desktop” header_4_font_size_tablet=”” header_4_font_size_phone=”” header_4_font_size_last_edited=”on|desktop” global_colors_info=”{}”]<\/p>\n

D\u00e9couvrir<\/h4>\n

[\/et_pb_text][et_pb_post_slider posts_number=”5″ include_categories=”969″ show_arrows=”off” use_manual_excerpt=”off” excerpt_length=”0″ show_meta=”off” image_placement=”top” use_bg_overlay=”off” use_text_overlay=”off” dot_nav_custom_color=”#5EC7ED” _builder_version=”4.16″ _module_preset=”412cf9f9-c22e-468d-92e3-f93d454642a9″ header_font=”Open Sans|600|||||||” header_text_color=”#5EC7ED” header_font_size=”20px” header_line_height=”1.2em” body_font=”Open Sans||||||||” body_text_align=”left” body_text_color=”#505659″ body_font_size=”18px” background_color=”#FFFFFF” custom_button=”on” button_text_size=”18px” button_bg_color=”#5EC7ED” button_border_width=”0px” button_border_radius=”0px” button_use_icon=”off” button_alignment=”center” button_custom_margin=”20px||0px||false|false” button_custom_padding=”10px|50px|10px|50px|true|true” custom_padding=”0px|||||” header_font_size_tablet=”” header_font_size_phone=”22px” header_font_size_last_edited=”on|phone” body_font_size_tablet=”” body_font_size_phone=”18px” body_font_size_last_edited=”on|phone” border_color_all_image=”#ffffff” border_width_bottom_image=”15px” text_shadow_style=”preset4″ text_shadow_vertical_length=”0em” global_colors_info=”{}”][\/et_pb_post_slider][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”4ae3b26e-eab0-4b6f-bd7b-05f173fca79b” custom_margin=”||-3px||false|false” global_colors_info=”{}”]<\/p>\n

Comprendre<\/h4>\n

[\/et_pb_text][et_pb_post_slider posts_number=”5″ include_categories=”1151,1216″ show_arrows=”off” use_manual_excerpt=”off” excerpt_length=”0″ show_meta=”off” image_placement=”top” use_bg_overlay=”off” use_text_overlay=”off” dot_nav_custom_color=”#5EC7ED” show_image_tablet=”” show_image_phone=”” show_image_last_edited=”on|phone” disabled_on=”off|off|off” _builder_version=”4.19.0″ _module_preset=”default” header_font=”Open Sans|600|||||||” header_text_color=”#5EC7ED” header_font_size=”20px” header_line_height=”1.2em” body_font=”Open Sans||||||||” body_text_align=”left” body_text_color=”#505659″ body_font_size=”18px” background_color=”#FFFFFF” custom_button=”on” button_text_size=”18px” button_bg_color=”#5EC7ED” button_border_width=”0px” button_border_radius=”0px” button_use_icon=”off” button_alignment=”center” button_custom_margin=”20px||0px||false|false” button_custom_padding=”10px|50px|10px|50px|true|true” custom_padding=”0px|||||” header_font_size_tablet=”” header_font_size_phone=”22px” header_font_size_last_edited=”on|phone” border_width_bottom_image=”15px” border_color_bottom_image=”#ffffff” text_shadow_style=”preset4″ text_shadow_vertical_length=”0em” global_colors_info=”{}”][\/et_pb_post_slider][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”4ae3b26e-eab0-4b6f-bd7b-05f173fca79b” custom_margin=”||-4px||false|false” global_colors_info=”{}”]<\/p>\n

Participer<\/h4>\n

[\/et_pb_text][et_pb_post_slider posts_number=”5″ include_categories=”1229,1319″ show_arrows=”off” use_manual_excerpt=”off” excerpt_length=”0″ show_meta=”off” image_placement=”top” use_bg_overlay=”off” use_text_overlay=”off” dot_nav_custom_color=”#5EC7ED” disabled_on=”off|off|off” _builder_version=”4.21.0″ _module_preset=”default” header_font=”Open Sans|600|||||||” header_text_color=”#5EC7ED” header_font_size=”20px” header_line_height=”1.2em” body_font=”Open Sans||||||||” body_text_align=”left” body_text_color=”#505659″ body_font_size=”18px” background_color=”#FFFFFF” custom_button=”on” button_text_size=”18px” button_bg_color=”#5EC7ED” button_border_width=”0px” button_border_radius=”0px” button_use_icon=”off” button_alignment=”center” button_custom_margin=”20px||0px||false|false” button_custom_padding=”10px|50px|10px|50px|true|true” custom_padding=”0px|||||” header_font_size_tablet=”” header_font_size_phone=”22px” header_font_size_last_edited=”on|phone” body_font_size_tablet=”” body_font_size_phone=”18px” body_font_size_last_edited=”on|phone” border_width_bottom_image=”15px” border_color_bottom_image=”#ffffff” text_shadow_style=”preset4″ text_shadow_vertical_length=”0em” global_colors_info=”{}”][\/et_pb_post_slider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

En live<\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][et_pb_code _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”]\n\n

\n\t\n \n
\n \n
\n

\n AYYOUB LAB<\/span>\n <\/span>\n Suivre<\/span>\n \n <\/path><\/svg>78<\/span>\n <\/path><\/svg>236<\/span>\n <\/span>\n <\/p>\n

\n Tumor immunity and immunotherapy (T2i) team.\nCancer Research Center of Toulouse @crctoncopole and @IUCTOncopoleICR\n#cancer #immunotherapy <\/p>\n <\/div>\n

\n
\n <\/path><\/svg> <\/div>\n \"TeamT2i\"\n <\/div>\n <\/a>\n<\/div>\n\n
\n \n
\n\n
\n <\/path><\/svg>Retweeter sur Twitter<\/span><\/a>\n AYYOUB LAB Retweet\u00e9<\/a>\n<\/div>\n\n
\n
\n \n \"melasphinx;\n <\/a>\n \n MELASPHINX<\/a>\n @melasphinx<\/a>\n \n \t\t ·<\/span>\n\t
\n 1 Sep 1697617831943184868<\/span><\/a>\n <\/div>\n <\/div>\n
\n <\/path><\/svg> <\/div>\n <\/div>\n\n
\n \t\t\t\t

#Postdoctoral fellow at the #Cancer Research Center, Toulouse, France on the impact of combining #TNF blockade and #immunotherapy on #immune responses and #melanoma liver metastases in #mice.
\n2 year contract from Nov 1, 2023
\nContact bruno.segui@inserm.fr before October 15, 2023.<\/p>\n\t\t\t\t\t\t\n \n\t \n \n <\/div>\n \n\t\n

\n \n <\/path><\/g><\/svg> R\u00e9pondre sur Twitter 1697617831943184868<\/span>\n <\/a>\n\n \n <\/path><\/svg> Retweeter sur Twitter 1697617831943184868<\/span>\n 9<\/span>\n <\/a>\n\n \n <\/path><\/g><\/svg> J\u2019aime sur Twitter 1697617831943184868<\/span>\n 12<\/span>\n <\/a>\n\n \n Twitter<\/span>\n 1697617831943184868<\/span>\n <\/a>\n \n\t<\/div>\n\n\t<\/div>\n\n <\/div>\n\n Voir plus<\/span><\/a>\n\n<\/span>\n<\/div>\n[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” background_color=”#f2efef” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

PRODUCTIONS SCIENTIFIQUES<\/strong><\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_toggle title=”PUBLICATIONS 2024″ open=”on” open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.22.1″ _module_preset=”default” title_text_color=”#ffffff” title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” global_colors_info=”{}”]

\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tFGRJFWV3<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2024<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 39181<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n
\n[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2023″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.22.1″ _module_preset=”default” title_text_color=”#ffffff” title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tFGRJFWV3<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2023<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 39181<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-dbeb0f22770813e86b8ef95975e5dae5%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228P27RTPE%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Spagnolo%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-28%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESpagnolo%2C%20Emanuela%2C%20Alejandra%20Martinez%2C%20Andrea%20Mascar%26%23xF3%3Bs-Mart%26%23xED%3Bnez%2C%20Josep%20Mar%26%23xED%3B-Alexandre%2C%20Mar%26%23xED%3Ba%20Carbonell%2C%20Eva%20Gonz%26%23xE1%3Blez-Cant%26%23xF3%3B%2C%20Eva%20Manuela%20Pena-Burgos%2C%20et%20al.%20%26%23x201C%3BEvaluation%20of%20Immune%20Infiltrates%20in%20Ovarian%20Endometriosis%20and%20Endometriosis-Associated%20Ovarian%20Cancer%3A%20Relationship%20with%20Histological%20and%20Clinical%20Features.%26%23x201D%3B%20%3Ci%3EInternational%20Journal%20of%20Molecular%20Sciences%3C%5C%2Fi%3E%2024%2C%20no.%2015%20%28July%2028%2C%202023%29%3A%2012083.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms241512083%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms241512083%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20Immune%20Infiltrates%20in%20Ovarian%20Endometriosis%20and%20Endometriosis-Associated%20Ovarian%20Cancer%3A%20Relationship%20with%20Histological%20and%20Clinical%20Features%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emanuela%22%2C%22lastName%22%3A%22Spagnolo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Mascar%5Cu00f3s-Mart%5Cu00ednez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josep%22%2C%22lastName%22%3A%22Mar%5Cu00ed-Alexandre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%22%2C%22lastName%22%3A%22Carbonell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%22%2C%22lastName%22%3A%22Gonz%5Cu00e1lez-Cant%5Cu00f3%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%20Manuela%22%2C%22lastName%22%3A%22Pena-Burgos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e1rbara%20Andrea%22%2C%22lastName%22%3A%22Mc%20Cormack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarai%22%2C%22lastName%22%3A%22Tom%5Cu00e1s-P%5Cu00e9rez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Gilabert-Estell%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22L%5Cu00f3pez-Carrasco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%22%2C%22lastName%22%3A%22Hidalgo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%20Aida%22%2C%22lastName%22%3A%22%5Cu00c1ngeles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9s%22%2C%22lastName%22%3A%22Redondo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandro%22%2C%22lastName%22%3A%22Gallego%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%22%2C%22lastName%22%3A%22Hern%5Cu00e1ndez%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20the%20association%20between%20ovarian%20endometriosis%20%28OE%29%20and%20endometriosis-associated%20ovarian%20cancer%20%28EAOC%29%20is%20extensively%20documented%2C%20and%20misfunction%20of%20the%20immune%20system%20might%20be%20involved.%20The%20primary%20objective%20of%20this%20study%20was%20to%20identify%20and%20compare%20the%20spatial%20distribution%20of%20tumour-infiltrating%20lymphocytes%20%28TILs%29%20and%20tumour-associated%20macrophages%20%28TAMs%29%20in%20OE%20and%20EAOC.%20Secondary%20objectives%20included%20the%20analysis%20of%20the%20relationship%20between%20immunosuppressive%20populations%20and%20T-cell%20exhaustion%20markers%20in%20both%20groups.%5CnMETHODS%3A%20TILs%20%28CD3%2C%20CD4%2C%20and%20CD8%29%20and%20macrophages%20%28CD163%29%20were%20assessed%20by%20immunochemistry.%20Exhaustion%20markers%20%28PD-1%2C%20TIM3%2C%20CD39%2C%20and%20FOXP3%29%20and%20their%20relationship%20with%20tumour-associated%20macrophages%20%28CD163%29%20were%20assessed%20by%20immunofluorescence%20on%20paraffin-embedded%20samples%20from%20n%20%3D%2043%20OE%20and%20n%20%3D%2054%20EAOC%20patients.%5CnRESULTS%3A%20we%20observed%20a%20predominantly%20intraepithelial%20CD3%2B%20distribution%20in%20OE%20but%20both%20an%20intraepithelial%20and%20stromal%20pattern%20in%20EAOC%20%28p%20%3C%200.001%29.%20TILs%20were%20more%20abundant%20in%20OE%20%28p%20%3C%200.001%29%2C%20but%20higher%20TILs%20significantly%20correlated%20with%20a%20longer%20overall%20survival%20and%20disease-free%20survival%20in%20EAOC%20%28p%20%3C%200.05%29.%20CD39%20and%20FOXP3%20significantly%20correlated%20with%20each%20other%20and%20CD163%20%28p%20%3C%200.05%29%20at%20the%20epithelial%20level%20in%20moderate%5C%2Fintense%20CD4%20EAOC%2C%20whereas%20in%20moderate%5C%2Fintense%20CD8%2B%2C%20PD-1%2B%20and%20TIM3%2B%20significantly%20correlated%20%28p%20%3D%200.009%29.%20Finally%2C%20T-cell%20exhaustion%20markers%20FOXP3-CD39%20were%20decreased%20and%20PD-1-TIM3%20were%20significantly%20increased%20in%20EAOC%20%28p%20%3C%200.05%29.%5CnCONCLUSIONS%3A%20the%20dysregulation%20of%20TILs%2C%20TAMs%2C%20and%20T-cell%20exhaustion%20might%20play%20a%20role%20in%20the%20malignization%20of%20OE%20to%20EAOC.%22%2C%22date%22%3A%222023-07-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fijms241512083%22%2C%22ISSN%22%3A%221422-0067%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222023-08-16T09%3A35%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22ATLKTGY4%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Feliu%20et%20al.%22%2C%22parsedDate%22%3A%222023-06-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFeliu%2C%20Virginie%2C%20Carlos%20Gomez-Roca%2C%20Marie%20Michelas%2C%20No%26%23xE9%3Bmie%20Th%26%23xE9%3Bbault%2C%20Fran%26%23xE7%3Boise%20Lauz%26%23xE9%3Bral-Vizcaino%2C%20Anna%20Salvioni%2C%20Lise%20Scandella%2C%20et%20al.%20%26%23x201C%3BDistant%20Antimetastatic%20Effect%20of%20Enterotropic%20Colon%20Cancer-Derived%20%26%23x391%3B4%26%23x3B2%3B7%2BCD8%2B%20T%20Cells.%26%23x201D%3B%20%3Ci%3EScience%20Immunology%3C%5C%2Fi%3E%208%2C%20no.%2084%20%28June%202%2C%202023%29%3A%20eadg8841.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciimmunol.adg8841%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciimmunol.adg8841%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Distant%20antimetastatic%20effect%20of%20enterotropic%20colon%20cancer-derived%20%5Cu03b14%5Cu03b27%2BCD8%2B%20T%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virginie%22%2C%22lastName%22%3A%22Feliu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Gomez-Roca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Michelas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22No%5Cu00e9mie%22%2C%22lastName%22%3A%22Th%5Cu00e9bault%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Lauz%5Cu00e9ral-Vizcaino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Salvioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lise%22%2C%22lastName%22%3A%22Scandella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emeline%22%2C%22lastName%22%3A%22Sarot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carine%22%2C%22lastName%22%3A%22Valle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille-Charlotte%22%2C%22lastName%22%3A%22Balan%5Cu00e7a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara-Maria%22%2C%22lastName%22%3A%22Scarlata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Delord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christel%22%2C%22lastName%22%3A%22Devaud%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20the%20high%20prognostic%20value%20of%20immune%20infiltrates%20in%20colorectal%20cancer%20%28CRC%29%2C%20metastatic%20disease%20remains%20resistant%20to%20immunotherapy%20by%20immune%20checkpoint%20blockade%20%28ICB%29.%20Here%2C%20we%20show%2C%20in%20metastatic%20CRC%20preclinical%20models%2C%20that%20orthotopically%20implanted%20primary%20colon%20tumors%20exert%20a%20colon-specific%20antimetastatic%20effect%20on%20distant%20hepatic%20lesions.%20Enterotropic%20%5Cu03b14%5Cu03b27%20integrin-expressing%20neoantigen-specific%20CD8%20T%20cells%20were%20key%20components%20of%20the%20antimetastatic%20effect.%20Accordingly%2C%20the%20presence%20of%20concomitant%20colon%20tumors%20improved%20control%20of%20liver%20lesions%20by%20anti-PD-L1%20proof-of-concept%20immunotherapy%20and%20generated%20protective%20immune%20memory%2C%20whereas%20partial%20depletion%20of%20%5Cu03b14%5Cu03b27%2B%20cells%20abrogated%20control%20of%20metastases.%20Last%2C%20in%20patients%20with%20metastatic%20CRC%2C%20response%20to%20ICB%20was%20associated%20with%20expression%20of%20%5Cu03b14%5Cu03b27%20integrin%20in%20metastases%20and%20with%20circulating%20%5Cu03b14%5Cu03b27%2B%20CD8%20T%20cells.%20Our%20findings%20identify%20a%20systemic%20cancer%20immunosurveillance%20role%20for%20gut-primed%20tumor-specific%20%5Cu03b14%5Cu03b27%2B%20CD8%20T%20cells.%22%2C%22date%22%3A%222023-06-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciimmunol.adg8841%22%2C%22ISSN%22%3A%222470-9468%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222023-06-09T12%3A24%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22P6GFFJPW%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mart%5Cu00ednez%20et%20al.%22%2C%22parsedDate%22%3A%222023-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMart%26%23xED%3Bnez%2C%20Alejandra%2C%20Cyrus%20Chargari%2C%20Elsa%20Kalbacher%2C%20Anne-Lise%20Gaillard%2C%20Alexandra%20Leary%2C%20Martin%20Koskas%2C%20Nicol%26%23xE1%3Bs%20Chopin%2C%20et%20al.%20%26%23x201C%3BRecommandations%20pour%20la%20pratique%20clinique%20Nice%5C%2FSaint-Paul-de-Vence%202022%26%23x2013%3B2023%26%23x202F%3B%3A%20prise%20en%20charge%20du%20cancer%20de%20l%26%23x2019%3Bendom%26%23xE8%3Btre%20localis%26%23xE9%3B.%26%23x201D%3B%20%3Ci%3EBulletin%20Du%20Cancer%3C%5C%2Fi%3E%20110%2C%20no.%206S%20%28June%202023%29%3A%206S20-26S33.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0007-4551%2823%2900331-4%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0007-4551%2823%2900331-4%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Recommandations%20pour%20la%20pratique%20clinique%20Nice%5C%2FSaint-Paul-de-Vence%202022%5Cu20132023%20%3A%20prise%20en%20charge%20du%20cancer%20de%20l%27endom%5Cu00e8tre%20localis%5Cu00e9.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Mart%5Cu00ednez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyrus%22%2C%22lastName%22%3A%22Chargari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elsa%22%2C%22lastName%22%3A%22Kalbacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Lise%22%2C%22lastName%22%3A%22Gaillard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Leary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Koskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicol%5Cu00e1s%22%2C%22lastName%22%3A%22Chopin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Agathe%22%2C%22lastName%22%3A%22Serre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Claire%22%2C%22lastName%22%3A%22Hardy-Bessard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ch%5Cu00e9rif%22%2C%22lastName%22%3A%22Akladios%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrice%22%2C%22lastName%22%3A%22Lecuru%22%7D%5D%2C%22abstractNote%22%3A%22Recommendations%20for%20clinical%20practice%2C%20Nice%5C%2FSaint-Paul-de-Vence%202022-2023%3A%20Management%20of%20localized%20endometrial%20cancer%20Endometrial%20cancer%20is%20the%20most%20frequent%20gynecological%20cancers%20in%20industrialized%20countries%20and%20its%20incidence%20increases.%20The%20newmolecularclassification%20allows%20determination%20of%20the%20risk%20of%20recurrence%20and%20helps%20orienting%20therapeutic%20management.%20Surgery%20remains%20the%20cornerstone%20of%20treatment.%20Minimally%20invasive%20approach%20must%20be%20preferred%20for%20stages%20I%20and%20II.%20Surgery%20includes%20hysterectomy%20with%20bilateral%20adnexectomy%2C%20sentinel%20lymph%20node%20biopsy%20even%20in%20high%20risk%20diseases%20and%20omentectomy%20for%20non-endometrioid%20tumors%20%28except%20in%20case%20of%20clear%20cells%20tumors%29.%20Fertility%20preservation%20can%20be%20proposed%20in%20low%20grade%2C%20stage%20I%20tumors%20without%20myometrial%20involvement.%20In%20stage%20III%5C%2FIV%20disease%2C%20lymph%20node%20debulking%20without%20totallymphadenectomy%20is%20indicated.%20In%20case%20of%20peritoneal%20carcinomatosis%2C%20first-line%20cytoreductive%20surgery%20is%20recommended%20if%20complete%20resection%20can%20be%20achieved.%20Adjuvant%20therapy%20is%20not%20recommended%20in%20low%20risk%20tumors.%20In%20intermediate%20risk%20tumors%2C%20curietherapy%20is%20indicated.%20In%20tumors%20with%20high-intermediate%20risk%2C%20curietherapy%20and%20external%20radiotherapy%20are%20indicated%20according%20to%20prognostic%20factors%20%28stage%20II%2C%20lymphovascular%20invasion%29%3B%20adjuvant%20chemotherapy%20can%20be%20considered%20on%20a%20case-by-case%20basis.%20In%20high%20risk%20tumors%2C%20chemotherapy%20and%20external%20radiotherapy%20are%20recommended%20using%20a%20concomitant%20or%20sequential%20approach.%22%2C%22date%22%3A%222023-06%22%2C%22language%22%3A%22fre%22%2C%22DOI%22%3A%2210.1016%5C%2FS0007-4551%2823%2900331-4%22%2C%22ISSN%22%3A%221769-6917%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222023-08-16T09%3A32%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22UP7QT2P5%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martinez%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMartinez%2C%20Alejandra%2C%20Fabrice%20Lecuru%2C%20Nicol%26%23xF2%3B%20Bizzarri%2C%20Cyrus%20Chargari%2C%20Anne%20Ducassou%2C%20Anna%20Fagotti%2C%20Francesco%20Fanfani%2C%20et%20al.%20%26%23x201C%3BPARa-AOrtic%20LymphAdenectomy%20in%20Locally%20Advanced%20Cervical%20Cancer%20%28PAROLA%20Trial%29%3A%20A%20GINECO%2C%20ENGOT%2C%20and%20GCIG%20Study.%26%23x201D%3B%20%3Ci%3EInternational%20Journal%20of%20Gynecological%20Cancer%3A%20Official%20Journal%20of%20the%20International%20Gynecological%20Cancer%20Society%3C%5C%2Fi%3E%2C%20January%2030%2C%202023%2C%20ijgc%26%23x2013%3B2022%26%23x2013%3B004223.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fijgc-2022-004223%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fijgc-2022-004223%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22PARa-aOrtic%20LymphAdenectomy%20in%20locally%20advanced%20cervical%20cancer%20%28PAROLA%20trial%29%3A%20a%20GINECO%2C%20ENGOT%2C%20and%20GCIG%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrice%22%2C%22lastName%22%3A%22Lecuru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicol%5Cu00f2%22%2C%22lastName%22%3A%22Bizzarri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyrus%22%2C%22lastName%22%3A%22Chargari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Ducassou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Fagotti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesco%22%2C%22lastName%22%3A%22Fanfani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Scambia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Cibula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berta%22%2C%22lastName%22%3A%22D%5Cu00edaz-Feijoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%22%2C%22lastName%22%3A%22Gil%20Moreno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%20Aida%22%2C%22lastName%22%3A%22Angeles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mustafa%20Zelal%22%2C%22lastName%22%3A%22Muallem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christhardt%22%2C%22lastName%22%3A%22Kohler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathieu%22%2C%22lastName%22%3A%22Luyckx%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederic%22%2C%22lastName%22%3A%22Kridelka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agnieszka%22%2C%22lastName%22%3A%22Rychlik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20G.%22%2C%22lastName%22%3A%22Gerestein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viola%22%2C%22lastName%22%3A%22Heinzelmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%20T.%22%2C%22lastName%22%3A%22Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Frumovitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwenael%22%2C%22lastName%22%3A%22Ferron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Betrian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Filleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%22%2C%22lastName%22%3A%22Fotopoulou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Querleu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22PAROLA%20Study%20group%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Positron%20emission%20tomography%5C%2Fcomputed%20tomography%20%28PET%5C%2FCT%29%20fails%20to%20detect%20approximately%2025%25%20of%20aortic%20lymph%20node%20metastasis%20in%20patients%20with%20PET%5C%2FCT%20stage%20IIIC1%20cervical%20cancer.%20Surgical%20staging%20could%20lead%20to%20treatment%20modification%20and%20to%20improved%20para-aortic%20and%20distant%20control.%5CnPRIMARY%20OBJECTIVES%3A%20To%20demonstrate%20if%20chemoradiation%20with%20tailored%20external%20beam%20radiation%20field%20based%20on%20surgical%20staging%20and%20pathologic%20examination%20of%20the%20para-aortic%20lymph%20node%20is%20associated%20with%20improved%203-year%20disease-free%20survival%20compared%20with%20patients%20staged%20with%20PET%5C%2FCT%20staging%20only.%5CnSTUDY%20HYPOTHESIS%3A%20Surgical%20staging%20followed%20by%20tailored%20chemoradiation%20will%20improve%20disease-free%20survival%20while%20avoiding%20unnecessary%20prophylactic%20extended-field%20chemoradiation%20in%20patients%20with%20International%20Federation%20of%20Gynecology%20and%20Obstetrics%20%28FIGO%29%20stage%20IIIC1%20cervical%20cancer.%5CnTRIAL%20DESIGN%3A%20This%20is%20an%20international%20multicenter%2C%20randomized%2C%20phase%20III%20study.%20Eligible%20patients%20will%20be%20randomized%201%3A1%20between%20PET%5C%2FCT%20staging%20followed%20by%20chemoradiation%20%28control%20arm%29%2C%20or%20surgical%20staging%20followed%20by%20tailored%20chemo-radiation%20%28experimental%20arm%29.%20Randomization%20will%20be%20stratified%20by%20tumor%20stage%20according%20to%20TNM%20classification%2C%20center%2C%20and%20adjuvant%20treatment.%5CnMAJOR%20INCLUSION%5C%2FEXCLUSION%20CRITERIA%3A%20Main%20inclusion%20criteria%20are%20histologically%20proven%20PET%5C%2FCT%20FIGO%20stage%20IIIC1%20cervical%20cancer.%20Main%20exclusion%20criteria%20include%20unequivocal%20positive%20common%20iliac%20or%20para-aortic%20lymph%20node%20at%20pre-therapeutic%20imaging%20PET%5C%2FCT.%5CnPRIMARY%20ENDPOINTS%3A%20The%20primary%20endpoint%20is%20disease-free%20survival%20defined%20as%20the%20time%20from%20randomization%20until%20first%20relapse%20%28local%2C%20regional%2C%20or%20distant%29%2C%20or%20death%20from%20any%20cause.%5CnSAMPLE%20SIZE%3A%20510%20eligible%20patients%20ESTIMATED%20DATES%20FOR%20COMPLETING%20ACCRUAL%20AND%20PRESENTING%20RESULTS%3A%20The%20estimated%20date%20for%20completing%20accrual%20will%20be%20Q2%202027.%20The%20estimated%20date%20for%20presenting%20results%20will%20be%20Q4%202030.%5CnTRIAL%20REGISTRATION%20NUMBER%3A%20NCT05581121.%22%2C%22date%22%3A%222023-01-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fijgc-2022-004223%22%2C%22ISSN%22%3A%221525-1438%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222023-02-01T09%3A52%3A28Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Spagnolo, Emanuela, Alejandra Martinez, Andrea Mascarós-Martínez, Josep Marí-Alexandre, María Carbonell, Eva González-Cantó, Eva Manuela Pena-Burgos, et al. “Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features.” International Journal of Molecular Sciences<\/i> 24, no. 15 (July 28, 2023): 12083. https:\/\/doi.org\/10.3390\/ijms241512083<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Feliu, Virginie, Carlos Gomez-Roca, Marie Michelas, Noémie Thébault, Françoise Lauzéral-Vizcaino, Anna Salvioni, Lise Scandella, et al. “Distant Antimetastatic Effect of Enterotropic Colon Cancer-Derived Α4β7+CD8+ T Cells.” Science Immunology<\/i> 8, no. 84 (June 2, 2023): eadg8841. https:\/\/doi.org\/10.1126\/sciimmunol.adg8841<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Martínez, Alejandra, Cyrus Chargari, Elsa Kalbacher, Anne-Lise Gaillard, Alexandra Leary, Martin Koskas, Nicolás Chopin, et al. “Recommandations pour la pratique clinique Nice\/Saint-Paul-de-Vence 2022–2023 : prise en charge du cancer de l’endomètre localisé.” Bulletin Du Cancer<\/i> 110, no. 6S (June 2023): 6S20-26S33. https:\/\/doi.org\/10.1016\/S0007-4551(23)00331-4<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Martinez, Alejandra, Fabrice Lecuru, Nicolò Bizzarri, Cyrus Chargari, Anne Ducassou, Anna Fagotti, Francesco Fanfani, et al. “PARa-AOrtic LymphAdenectomy in Locally Advanced Cervical Cancer (PAROLA Trial): A GINECO, ENGOT, and GCIG Study.” International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society<\/i>, January 30, 2023, ijgc–2022–004223. https:\/\/doi.org\/10.1136\/ijgc-2022-004223<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\n

[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2022″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.19.0″ _module_preset=”default” title_text_color=”#ffffff” title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” global_colors_info=”{}”]

\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tFGRJFWV3<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2022<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 39181<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-a8b31a85410eeb4692991c4cdd40fb34%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%226QXZUPH7%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martinez%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-16%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMartinez%2C%20Alejandra%2C%20Berta%20D%26%23xED%3Baz-Feijoo%2C%20and%20Denis%20Querleu.%20%26%23x201C%3BPara-Aortic%20Lymphadenectomy%20in%20Cervical%20Cancer%20Deserves%20a%20New%20Trial.%26%23x201D%3B%20%3Ci%3EInternational%20Journal%20of%20Gynecologic%20Cancer%3C%5C%2Fi%3E%2C%20September%2016%2C%202022%2C%20ijgc%26%23x2013%3B2022%26%23x2013%3B003910.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fijgc-2022-003910%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fijgc-2022-003910%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Para-aortic%20lymphadenectomy%20in%20cervical%20cancer%20deserves%20a%20new%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berta%22%2C%22lastName%22%3A%22D%5Cu00edaz-Feijoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Querleu%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222022-09-16%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fijgc-2022-003910%22%2C%22ISSN%22%3A%221048-891X%2C%201525-1438%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fijgc.bmj.com%5C%2Flookup%5C%2Fdoi%5C%2F10.1136%5C%2Fijgc-2022-003910%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222022-09-19T08%3A57%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22E99DSI56%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martinez-Gomez%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-28%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMartinez-Gomez%2C%20Carlos%2C%20Marie%20Michelas%2C%20Clara-Maria%20Scarlata%2C%20Anna%20Salvioni%2C%20Carlos%20Gomez-Roca%2C%20Victor%20Sarradin%2C%20Fran%26%23xE7%3Boise%20Lauz%26%23xE9%3Bral-Vizcaino%2C%20et%20al.%20%26%23x201C%3BCirculating%20Exhausted%20PD-1%2BCD39%2B%20Helper%20CD4%20T%20Cells%20Are%20Tumor-Antigen-Specific%20and%20Predict%20Response%20to%20PD-1%5C%2FPD-L1%20Axis%20Blockade.%26%23x201D%3B%20%3Ci%3ECancers%3C%5C%2Fi%3E%2014%2C%20no.%2015%20%28July%2028%2C%202022%29%3A%203679.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers14153679%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers14153679%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Circulating%20Exhausted%20PD-1%2BCD39%2B%20Helper%20CD4%20T%20Cells%20Are%20Tumor-Antigen-Specific%20and%20Predict%20Response%20to%20PD-1%5C%2FPD-L1%20Axis%20Blockade%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Martinez-Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Michelas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara-Maria%22%2C%22lastName%22%3A%22Scarlata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Salvioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Gomez-Roca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Sarradin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Lauz%5Cu00e9ral-Vizcaino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virginie%22%2C%22lastName%22%3A%22F%5Cu00e9liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agn%5Cu00e8s%22%2C%22lastName%22%3A%22Dupret-Bories%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gw%5Cu00e9na%5Cu00ebl%22%2C%22lastName%22%3A%22Ferron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Sarini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christel%22%2C%22lastName%22%3A%22Devaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Delord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille-Charlotte%22%2C%22lastName%22%3A%22Balan%5Cu00e7a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%5D%2C%22abstractNote%22%3A%22Tumor-infiltrating%20exhausted%20PD-1hiCD39%2B%20tumor-antigen%20%28Ag%29-specific%20CD4%20T%20cells%20contribute%20to%20the%20response%20to%20immune%20checkpoint%20blockade%20%28ICB%29%2C%20but%20their%20circulating%20counterparts%2C%20which%20could%20represent%20accessible%20biomarkers%2C%20have%20not%20been%20assessed.%20Here%2C%20we%20analyzed%20circulating%20PD-1%2BCD39%2B%20CD4%20T%20cells%20and%20show%20that%20this%20population%20was%20present%20at%20higher%20proportions%20in%20cancer%20patients%20than%20in%20healthy%20individuals%20and%20was%20enriched%20in%20activated%20HLA-DR%2B%20and%20ICOS%2B%20and%20proliferating%20KI67%2B%20cells%2C%20indicative%20of%20their%20involvement%20in%20ongoing%20immune%20responses.%20Among%20memory%20CD4%20T%20cells%2C%20this%20population%20contained%20the%20lowest%20proportions%20of%20cells%20producing%20effector%20cytokines%2C%20suggesting%20they%20were%20exhausted.%20In%20patients%20with%20HPV-induced%20malignancies%2C%20the%20PD-1%2BCD39%2B%20population%20contained%20high%20proportions%20of%20HPV%20Ag-specific%20T%20cells.%20In%20patients%20treated%20by%20ICB%20for%20HPV-induced%20tumors%2C%20the%20proportion%20of%20circulating%20PD-1%2BCD39%2B%20CD4%20T%20cells%20was%20predictive%20of%20the%20clinical%20response.%20Our%20results%20identify%20CD39%20expression%20as%20a%20surrogate%20marker%20of%20circulating%20helper%20tumor-Ag-specific%20CD4%20T%20cells.%22%2C%22date%22%3A%222022-07-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fcancers14153679%22%2C%22ISSN%22%3A%222072-6694%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222022-08-22T09%3A42%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22BUCNKVTA%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martinez%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-23%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMartinez%2C%20Alejandra%2C%20Elodie%20Chantalat%2C%20Martina%20Aida%20Angeles%2C%20Gw%26%23xE9%3Bna%26%23xEB%3Bl%20Ferron%2C%20Anne%20Ducassou%2C%20Manon%20Daix%2C%20Justine%20Attal%2C%20Sarah%20B%26%23xE9%3Btrian%2C%20Am%26%23xE9%3Blie%20Lusque%2C%20and%20Erwan%20Gabiache.%20%26%23x201C%3BMetabolic%20Activity%20Determines%20Survival%20Depending%20on%20the%20Level%20of%20Lymph%20Node%20Involvement%20in%20Cervical%20Cancer.%26%23x201D%3B%20%3Ci%3EBMC%20Cancer%3C%5C%2Fi%3E%2022%2C%20no.%201%20%28July%2023%2C%202022%29%3A%20810.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12885-022-09785-w%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12885-022-09785-w%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Metabolic%20activity%20determines%20survival%20depending%20on%20the%20level%20of%20lymph%20node%20involvement%20in%20cervical%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%22%2C%22lastName%22%3A%22Chantalat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%20Aida%22%2C%22lastName%22%3A%22Angeles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gw%5Cu00e9na%5Cu00ebl%22%2C%22lastName%22%3A%22Ferron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Ducassou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Daix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justine%22%2C%22lastName%22%3A%22Attal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22B%5Cu00e9trian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Lusque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erwan%22%2C%22lastName%22%3A%22Gabiache%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20To%20assess%20the%20impact%20of%20PET%5C%2FCT%20functional%20parameters%20on%20survival%2C%20locoregional%2C%20and%20distant%20failure%20according%20to%20the%20most%20distant%20level%20of%20lymph%20node%20%5B18F%5DFDG%20uptake%20in%20patients%20with%20locally%20advanced%20cervical%20cancer%20%28LACC%29.%5CnMETHODS%3A%20Retrospective%20study%20including%20148%20patients%20with%20LACC%20treated%20with%20concurrent%20chemoradiotherapy%20after%20PET%5C%2FCT%20and%20para-aortic%20lymph%20node%20%28PALN%29%20surgical%20staging.%20Two%20senior%20nuclear%20medicine%20physicians%20reviewed%20all%20PET%5C%2FCT%20exams%20and%20retrieved%20tumor%20and%20lymph%20node%20metabolic%20parameters%3A%20SUVmax%2C%20MTV%2C%20TLG.%20Oncological%20outcomes%20according%20to%20metabolic%20parameters%20and%20level%20of%20lymph%20node%20spread%20on%20PET%5C%2FCT%20were%20assessed.%5CnRESULTS%3A%20In%20patients%20without%20lymph%20node%20uptake%20on%20PET%5C%2FCT%2C%20high%20MTV%20values%20of%20the%20cervical%20tumor%20were%20associated%20with%20DFS%20%28HR%5Cu2009%3D%5Cu20095.14%2095%25CI%5Cu2009%3D%5Cu2009%5B2.15-12.31%5D%29%2C%20OS%20%28HR%5Cu2009%3D%5Cu20096.10%2095%25CI%5Cu2009%3D%5Cu2009%5B1.89-19.70%5D%29%2C%20and%20time%20to%20distant%20%28HR%5Cu2009%3D%5Cu20094.73%2095%25CI%5Cu2009%3D%5Cu2009%5B1.55-14.44%5D%29%20and%20locoregional%20recurrence%20%28HR%5Cu2009%3D%5Cu20095.18%2095%25CI%5Cu2009%3D%5Cu2009%5B1.72-15.60%5D%29.%20In%20patients%20with%20pelvic%20lymph%20node%20%28PLN%29%20uptake%20but%20without%20PALN%20uptake%20on%20%5B18F%5DFDG-PET%5C%2FCT%2C%20high%20MTV%20values%20of%20the%20cervical%20tumor%20were%20associated%20with%20DFS%20%28HR%5Cu2009%3D%5Cu20093.17%2095%25CI%5Cu2009%3D%5Cu2009%5B1.02-9.83%5D%29%20and%20OS%20%28HR%5Cu2009%3D%5Cu20093.46%2095%25CI%5Cu2009%3D%5Cu2009%5B0.96-12.50%5D%29%2C%20and%20the%20number%20of%20PLN%20fixations%20was%20associated%20with%20DFS%20%28HR%5Cu2009%3D%5Cu20091.30%2095%25CI%5Cu2009%3D%5Cu2009%5B1.10-1.53%5D%29%2C%20OS%20%28HR%5Cu2009%3D%5Cu20091.35%2095%25CI%5Cu2009%3D%5Cu2009%5B1.11-1.64%5D%29%2C%20and%20time%20to%20distant%20%28HR%5Cu2009%3D%5Cu20091.35%2095%25CI%5Cu2009%3D%5Cu2009%5B1.08-1.67%5D%29%20and%20locoregional%20recurrence%20%28HR%5Cu2009%3D%5Cu20091.31%2095%25CI%5Cu2009%3D%5Cu2009%5B1.08-1.59%5D%29.%20There%20was%20no%20significant%20association%20between%20cervical%20tumor%20metabolic%20or%20lymph%20node%20metrics%20and%20survival%20outcome%20in%20patients%20with%20PALN%20uptake.%5CnCONCLUSIONS%3A%20Cervical%20MTV%20is%20more%20accurate%20than%20SUVmax%20to%20predict%20survival%20outcome%20in%20patients%20with%20locoregional%20disease%20confined%20to%20the%20pelvis%20and%20should%20be%20implemented%20in%20routine%20clinical%20practice.%20Prognostic%20value%20of%20metabolic%20metrics%20disappears%20with%20PALN%20uptake%2C%20which%20is%20associated%20with%20distant%20failure%20in%20nearly%20half%20of%20patients.%22%2C%22date%22%3A%222022-07-23%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12885-022-09785-w%22%2C%22ISSN%22%3A%221471-2407%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222022-08-25T07%3A40%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22MXLCE4LK%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Angeles%20et%20al.%22%2C%22parsedDate%22%3A%222022-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAngeles%2C%20Martina%20Aida%2C%20Alicia%20Hern%26%23xE1%3Bndez%2C%20Asunci%26%23xF3%3Bn%20P%26%23xE9%3Brez-Benavente%2C%20Bastien%20Cabarrou%2C%20Emanuela%20Spagnolo%2C%20Agnieszka%20Rychlik%2C%20Amel%20Daboussi%2C%20et%20al.%20%26%23x201C%3BThe%20Effect%20of%20Major%20Postoperative%20Complications%20on%20Recurrence%20and%20Long-Term%20Survival%20after%20Cytoreductive%20Surgery%20for%20Ovarian%20Cancer.%26%23x201D%3B%20%3Ci%3EGynecologic%20Oncology%3C%5C%2Fi%3E%20166%2C%20no.%201%20%28July%202022%29%3A%208%26%23x2013%3B17.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ygyno.2022.05.002%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ygyno.2022.05.002%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20effect%20of%20major%20postoperative%20complications%20on%20recurrence%20and%20long-term%20survival%20after%20cytoreductive%20surgery%20for%20ovarian%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%20Aida%22%2C%22lastName%22%3A%22Angeles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%22%2C%22lastName%22%3A%22Hern%5Cu00e1ndez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asunci%5Cu00f3n%22%2C%22lastName%22%3A%22P%5Cu00e9rez-Benavente%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bastien%22%2C%22lastName%22%3A%22Cabarrou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emanuela%22%2C%22lastName%22%3A%22Spagnolo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agnieszka%22%2C%22lastName%22%3A%22Rychlik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amel%22%2C%22lastName%22%3A%22Daboussi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federico%22%2C%22lastName%22%3A%22Migliorelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22B%5Cu00e9trian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gw%5Cu00e9na%5Cu00ebl%22%2C%22lastName%22%3A%22Ferron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%22%2C%22lastName%22%3A%22Gil-Moreno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Guyon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20assess%20the%20impact%20on%20survival%20of%20major%20postoperative%20complications%20and%20to%20identify%20the%20factors%20associated%20with%20these%20complications%20in%20patients%20with%20advanced%20ovarian%20cancer%20after%20cytoreductive%20surgery.%5CnMETHODS%3A%20We%20designed%20a%20retrospective%20multicenter%20study%20collecting%20data%20from%20patients%20with%20IIIC-IV%20FIGO%20Stage%20ovarian%20cancer%20who%20had%20undergone%20either%20primary%20debulking%20surgery%20%28PDS%29%2C%20early%20interval%20debulking%20surgery%20%28IDS%29%20after%203-4%20cycles%20of%20neoadjuvant%20chemotherapy%2C%20or%20delayed%20debulking%20surgery%20%28DDS%29%20after%206%20cycles%2C%20with%20minimal%20or%20no%20residual%20disease%2C%20from%20January%202008%20to%20December%202015.%20Univariable%20and%20multivariable%20analyses%20were%20conducted%20to%20identify%20factors%20associated%20with%20major%20surgical%20complications%20%28%5Cu2265Grade%203%29.%20We%20assessed%20disease-free%20survival%20%28DFS%29%20and%20overall%20survival%20%28OS%29%20rates%20according%20to%20the%20occurrence%20of%20major%20postoperative%20complications.%5CnRESULTS%3A%20549%20women%20were%20included.%20The%20overall%20rate%20of%20major%20surgical%20complications%20was%2022.4%25.%20Patients%20who%20underwent%20PDS%20had%20a%20higher%20rate%20of%20major%20complications%20%2828.6%25%29%20than%20patients%20who%20underwent%20either%20early%20IDS%20%2823.2%25%29%20or%20DDS%20%2814.0%25%29.%20Multivariable%20analysis%20revealed%20that%20extensive%20peritonectomy%20and%20surgical%20timing%20were%20associated%20with%20the%20occurrence%20of%20major%20complications.%20Median%20DFS%20and%20OS%20were%2016.9%20months%20%2895%25CI%20%3D%20%5B13.7-18.4%5D%29%20and%2048.0%20months%20%2895%25CI%20%3D%20%5B37.2-73.1%5D%29%20for%20the%20group%20of%20patients%20with%20major%20complications%2C%20and%2020.1%20months%20%2895%25CI%20%3D%20%5B18.6-22.4%5D%29%20and%2056.7%20months%20%2895%25CI%20%3D%20%5B51.2-70.4%5D%29%20for%20the%20group%20without%20major%20complications.%20Multivariable%20analysis%20revealed%20that%20major%20surgical%20complications%20were%20significantly%20associated%20with%20DFS%2C%20but%20not%20with%20OS.%5CnCONCLUSIONS%3A%20Patients%20who%20experienced%20major%20surgical%20complications%20had%20reduced%20DFS%2C%20compared%20with%20patients%20without%20major%20morbidity.%20Extensive%20peritonectomy%20and%20surgical%20timing%20were%20predictive%20factors%20of%20postoperative%20morbidity.%22%2C%22date%22%3A%222022-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ygyno.2022.05.002%22%2C%22ISSN%22%3A%221095-6859%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22CF9MRXB4%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222022-06-28T07%3A46%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22B9WBALIX%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Daix%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-21%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDaix%2C%20Manon%2C%20Carlos%20Martinez%20Gomez%2C%20Martina%20Aida%20Angeles%2C%20St%26%23xE9%3Bphanie%20Tock%2C%20Laurence%20Gladieff%2C%20Erwan%20Gabiache%2C%20Eliane%20Mery%2C%20Alejandra%20Martinez%2C%20David%20Cibula%2C%20and%20Gw%26%23xE9%3Bna%26%23xEB%3Bl%20Ferron.%20%26%23x201C%3BExtended%20Pelvic%20Resection%20for%20Gynecological%20Malignancies%3A%20A%20Review%20of%20out-of-the-Box%20Surgery.%26%23x201D%3B%20%3Ci%3EGynecologic%20Oncology%3C%5C%2Fi%3E%2C%20March%2021%2C%202022%2C%20S0090-8258%2822%2900174-3.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ygyno.2022.03.002%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ygyno.2022.03.002%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extended%20pelvic%20resection%20for%20gynecological%20malignancies%3A%20A%20review%20of%20out-of-the-box%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Daix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Martinez%20Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%20Aida%22%2C%22lastName%22%3A%22Angeles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Tock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Gladieff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erwan%22%2C%22lastName%22%3A%22Gabiache%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Mery%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Cibula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gw%5Cu00e9na%5Cu00ebl%22%2C%22lastName%22%3A%22Ferron%22%7D%5D%2C%22abstractNote%22%3A%22The%20term%20%27out-of-the-box%20surgery%27%20in%20gynecologic%20oncology%20was%20recently%20coined%20to%20describe%20the%20resection%20of%20tumor%20growing%20out%20of%20the%20endopelvic%20cavity.%20In%20the%20specific%20case%20of%20pelvic%20sidewall%20involvement%2C%20a%20laterally%20extended%20pelvic%20resection%20may%20be%20required.%20As%20previously%20defined%20by%20H%5Cu00f6ckel%2C%20this%20resection%20requires%20the%20en%20bloc%20removal%20of%20structures%20including%20the%20pelvic%20sidewall%20muscles%2C%20bones%2C%20nerves%2C%20and%5C%2For%20major%20vessels.%20This%20complex%20radical%20procedure%20leads%20to%20tumor-free%20margins%20in%20more%20than%2075%25%20of%20the%20patients%2C%20with%20reliable%20functional%20results.%20The%20rate%20of%20recurrence%20and%20overall%20survival%20are%20directly%20correlated%20with%20clear%20resection%20margins.%20Progress%20in%20imaging%2C%20surgical%20techniques%2C%20and%20perioperative%20care%20currently%20offer%20the%20opportunity%20to%20attempt%20surgical%20curative%20resection%20in%20selected%20patients%20for%20whom%20palliative%20therapy%20was%20the%20only%20alternative.%20However%2C%20the%20procedure%20is%20associated%20with%20a%20high%20rate%20of%20major%20postoperative%20complications%20affecting%20up%20to%2060%25%20of%20patients.%20Multidisciplinary%20expert%20centers%20are%20the%20most%20likely%20to%20achieve%20this%20complex%20surgery%20with%20favorable%20oncological%20outcomes.%20The%20aim%20of%20this%20review%20is%20to%20summarize%20the%20key%20issues%20of%20out-of-the-box%20surgery%20in%20gynecologic%20cancer.%22%2C%22date%22%3A%222022-03-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ygyno.2022.03.002%22%2C%22ISSN%22%3A%221095-6859%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22CF9MRXB4%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222022-10-04T08%3A10%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22RAE2P5XW%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Daix%20et%20al.%22%2C%22parsedDate%22%3A%222022-01%22%2C%22numChildren%22%3A8%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDaix%2C%20Manon%2C%20Martina%20Aida%20Angeles%2C%20H%26%23xE9%3Bl%26%23xE8%3Bne%20Leray%2C%20Kelig%20Vergriete%2C%20Alejandra%20Martinez%2C%20and%20Gwenael%20Ferron.%20%26%23x201C%3BAnterior%20Pelvic%20Exenteration%20and%20Laterally%20Extended%20Pelvic%20Resection%3A%20A%20Step%20by%20Step%20Procedure.%26%23x201D%3B%20%3Ci%3EInternational%20Journal%20of%20Gynecological%20Cancer%3A%20Official%20Journal%20of%20the%20International%20Gynecological%20Cancer%20Society%3C%5C%2Fi%3E%2032%2C%20no.%201%20%28January%202022%29%3A%20107%26%23x2013%3B8.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fijgc-2021-003047%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fijgc-2021-003047%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Anterior%20pelvic%20exenteration%20and%20laterally%20extended%20pelvic%20resection%3A%20a%20step%20by%20step%20procedure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Daix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%20Aida%22%2C%22lastName%22%3A%22Angeles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Leray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelig%22%2C%22lastName%22%3A%22Vergriete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwenael%22%2C%22lastName%22%3A%22Ferron%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222022-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fijgc-2021-003047%22%2C%22ISSN%22%3A%221525-1438%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22CF9MRXB4%22%2C%223U3NWA3K%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222022-10-04T08%3A09%3A32Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Martinez, Alejandra, Berta Díaz-Feijoo, and Denis Querleu. “Para-Aortic Lymphadenectomy in Cervical Cancer Deserves a New Trial.” International Journal of Gynecologic Cancer<\/i>, September 16, 2022, ijgc–2022–003910. https:\/\/doi.org\/10.1136\/ijgc-2022-003910<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Martinez-Gomez, Carlos, Marie Michelas, Clara-Maria Scarlata, Anna Salvioni, Carlos Gomez-Roca, Victor Sarradin, Françoise Lauzéral-Vizcaino, et al. “Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1\/PD-L1 Axis Blockade.” Cancers<\/i> 14, no. 15 (July 28, 2022): 3679. https:\/\/doi.org\/10.3390\/cancers14153679<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Martinez, Alejandra, Elodie Chantalat, Martina Aida Angeles, Gwénaël Ferron, Anne Ducassou, Manon Daix, Justine Attal, Sarah Bétrian, Amélie Lusque, and Erwan Gabiache. “Metabolic Activity Determines Survival Depending on the Level of Lymph Node Involvement in Cervical Cancer.” BMC Cancer<\/i> 22, no. 1 (July 23, 2022): 810. https:\/\/doi.org\/10.1186\/s12885-022-09785-w<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Angeles, Martina Aida, Alicia Hernández, Asunción Pérez-Benavente, Bastien Cabarrou, Emanuela Spagnolo, Agnieszka Rychlik, Amel Daboussi, et al. “The Effect of Major Postoperative Complications on Recurrence and Long-Term Survival after Cytoreductive Surgery for Ovarian Cancer.” Gynecologic Oncology<\/i> 166, no. 1 (July 2022): 8–17. https:\/\/doi.org\/10.1016\/j.ygyno.2022.05.002<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Daix, Manon, Carlos Martinez Gomez, Martina Aida Angeles, Stéphanie Tock, Laurence Gladieff, Erwan Gabiache, Eliane Mery, Alejandra Martinez, David Cibula, and Gwénaël Ferron. “Extended Pelvic Resection for Gynecological Malignancies: A Review of out-of-the-Box Surgery.” Gynecologic Oncology<\/i>, March 21, 2022, S0090-8258(22)00174-3. https:\/\/doi.org\/10.1016\/j.ygyno.2022.03.002<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Daix, Manon, Martina Aida Angeles, Hélène Leray, Kelig Vergriete, Alejandra Martinez, and Gwenael Ferron. “Anterior Pelvic Exenteration and Laterally Extended Pelvic Resection: A Step by Step Procedure.” International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society<\/i> 32, no. 1 (January 2022): 107–8. https:\/\/doi.org\/10.1136\/ijgc-2021-003047<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n
\n[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2021″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.16″ _module_preset=”default” title_text_color=”#ffffff” title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” global_colors_info=”{}”]
\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tFGRJFWV3<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2021<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 39181<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-11a7535f56653eff35cd34d45a384e4f%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%2244MCBTVI%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Angeles%20et%20al.%22%2C%22parsedDate%22%3A%222021-11%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAngeles%2C%20Martina%20Aida%2C%20H%26%23xE9%3Bl%26%23xE8%3Bne%20Leray%2C%20Federico%20Migliorelli%2C%20Manon%20Daix%2C%20Alejandra%20Martinez%2C%20and%20Gwenael%20Ferron.%20%26%23x201C%3BSurgical%20Approach%20of%20the%20Left%20Upper%20Quadrant%20for%20Ovarian%20Cancer%20in%2010%20Steps.%26%23x201D%3B%20%3Ci%3EInternational%20Journal%20of%20Gynecological%20Cancer%3A%20Official%20Journal%20of%20the%20International%20Gynecological%20Cancer%20Society%3C%5C%2Fi%3E%2031%2C%20no.%2011%20%28November%202021%29%3A%201488%26%23x2013%3B89.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fijgc-2021-002963%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fijgc-2021-002963%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Surgical%20approach%20of%20the%20left%20upper%20quadrant%20for%20ovarian%20cancer%20in%2010%20steps%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%20Aida%22%2C%22lastName%22%3A%22Angeles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Leray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federico%22%2C%22lastName%22%3A%22Migliorelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Daix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwenael%22%2C%22lastName%22%3A%22Ferron%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222021-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fijgc-2021-002963%22%2C%22ISSN%22%3A%221525-1438%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22CF9MRXB4%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222022-01-27T15%3A12%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22UV5Q4HZY%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cerapio%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECerapio%2C%20Juan-Pablo%2C%20Marion%20Perrier%2C%20Camille-Charlotte%20Balan%26%23xE7%3Ba%2C%20Pauline%20Gravelle%2C%20Fr%26%23xE9%3Bderic%20Pont%2C%20Christel%20Devaud%2C%20Don-Marc%20Franchini%2C%20et%20al.%20%26%23x201C%3BPhased%20Differentiation%20of%20%26%23x393%3B%26%23x3B4%3B%20T%20and%20T%20CD8%20Tumor-Infiltrating%20Lymphocytes%20Revealed%20by%20Single-Cell%20Transcriptomics%20of%20Human%20Cancers.%26%23x201D%3B%20%3Ci%3EOncoimmunology%3C%5C%2Fi%3E%2010%2C%20no.%201%20%282021%29%3A%201939518.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F2162402X.2021.1939518%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F2162402X.2021.1939518%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Phased%20differentiation%20of%20%5Cu03b3%5Cu03b4%20T%20and%20T%20CD8%20tumor-infiltrating%20lymphocytes%20revealed%20by%20single-cell%20transcriptomics%20of%20human%20cancers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan-Pablo%22%2C%22lastName%22%3A%22Cerapio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%22%2C%22lastName%22%3A%22Perrier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille-Charlotte%22%2C%22lastName%22%3A%22Balan%5Cu00e7a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pauline%22%2C%22lastName%22%3A%22Gravelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9deric%22%2C%22lastName%22%3A%22Pont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christel%22%2C%22lastName%22%3A%22Devaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Don-Marc%22%2C%22lastName%22%3A%22Franchini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virginie%22%2C%22lastName%22%3A%22F%5Cu00e9liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Tosolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carine%22%2C%22lastName%22%3A%22Valle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9deric%22%2C%22lastName%22%3A%22Lopez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Quillet-Mary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loic%22%2C%22lastName%22%3A%22Ysebaert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Pierre%22%2C%22lastName%22%3A%22Delord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Laurent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Jacques%22%2C%22lastName%22%3A%22Fournie%22%7D%5D%2C%22abstractNote%22%3A%22%5Cu03b3%5Cu03b4%20T%20lymphocytes%20diverge%20from%20conventional%20T%20CD8%20lymphocytes%20for%20ontogeny%2C%20homing%2C%20and%20antigen%20specificity%2C%20but%20whether%20their%20differentiation%20in%20tumors%20also%20deviates%20was%20unknown.%20Using%20innovative%20analyses%20of%20our%20original%20and%20~150%20published%20single-cell%20RNA%20sequencing%20datasets%20validated%20by%20phenotyping%20of%20human%20tumors%20and%20murine%20models%2C%20here%20we%20present%20the%20first%20high-resolution%20view%20of%20human%20%5Cu03b3%5Cu03b4%20T%20cell%20differentiation%20in%20cancer.%20While%20%5Cu03b3%5Cu03b4%20T%20lymphocytes%20prominently%20encompass%20TCRV%5Cu03b39%20cells%20more%20differentiated%20than%20T%20CD8%20in%20healthy%20donor%27s%20blood%2C%20a%20different%20scenario%20is%20unveiled%20in%20tumors.%20Solid%20tumors%20and%20lymphomas%20are%20infiltrated%20by%20a%20majority%20of%20TCRV%5Cu03b3non9%20%5Cu03b3%5Cu03b4%20T%20cells%20which%20are%20quantitatively%20correlated%20and%20remarkably%20aligned%20with%20T%20CD8%20for%20differentiation%2C%20exhaustion%2C%20gene%20expression%20profile%2C%20and%20response%20to%20immune%20checkpoint%20therapy.%20This%20cancer-wide%20association%20is%20critical%20for%20developing%20cancer%20immunotherapies.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F2162402X.2021.1939518%22%2C%22ISSN%22%3A%222162-402X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QS3I9WIA%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-11-22T16%3A29%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22W6US9RSD%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Khalifa%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKhalifa%2C%20Jonathan%2C%20Julien%20Mazieres%2C%20Carlos%20Gomez-Roca%2C%20Maha%20Ayyoub%2C%20and%20Elizabeth%20Cohen-Jonathan%20Moyal.%20%26%23x201C%3BRadiotherapy%20in%20the%20Era%20of%20Immunotherapy%26%23xA0%3BWith%20a%20Focus%20on%20Non-Small-Cell%20Lung%20Cancer%3A%20Time%20to%20Revisit%20Ancient%20Dogmas%3F%26%23x201D%3B%20%3Ci%3EFrontiers%20in%20Oncology%3C%5C%2Fi%3E%2011%20%282021%29%3A%20662236.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffonc.2021.662236%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffonc.2021.662236%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Radiotherapy%20in%20the%20Era%20of%20Immunotherapy%5Cu00a0With%20a%20Focus%20on%20Non-Small-Cell%20Lung%20Cancer%3A%20Time%20to%20Revisit%20Ancient%20Dogmas%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Khalifa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Mazieres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Gomez-Roca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20Cohen-Jonathan%22%2C%22lastName%22%3A%22Moyal%22%7D%5D%2C%22abstractNote%22%3A%22Radiation-induced%20immune%20effects%20have%20been%20extensively%20deciphered%20over%20the%20last%20few%20years%2C%20leading%20to%20the%20concept%20of%20the%20dual%20immune%20effect%20of%20radiotherapy%20with%20both%20immunostimulatory%20and%20immunosuppressive%20effects.%20This%20explains%20why%20radiotherapy%20alone%20is%20not%20able%20to%20drive%20a%20strong%20anti-tumor%20immune%20response%20in%20most%20cases%2C%20hence%20underlining%20the%20rationale%20for%20combining%20both%20radiotherapy%20and%20immunotherapy.%20This%20association%20has%20generated%20considerable%20interest%20and%20hundreds%20of%20trials%20are%20currently%20ongoing%20to%20assess%20such%20an%20association%20in%20oncology.%20However%2C%20while%20some%20trials%20have%20provided%20unprecedented%20results%20or%20shown%20much%20promise%2C%20many%20hopes%20have%20been%20dashed.%20Questions%20remain%2C%20therefore%2C%20as%20to%20how%20to%20optimize%20the%20combination%20of%20these%20treatment%20modalities.%20This%20narrative%20review%20aims%20at%20revisiting%20the%20old%2C%20well-established%20concepts%20of%20radiotherapy%20relating%20to%20dose%2C%20fractionation%2C%20target%20volumes%20and%20organs%20at%20risk%20in%20the%20era%20of%20immunotherapy.%20We%20then%20propose%20potential%20innovative%20approaches%20to%20be%20further%20assessed%20when%20considering%20a%20radio-immunotherapy%20association%2C%20especially%20in%20the%20field%20of%20non-small-cell%20lung%20cancer%20%28NSCLC%29.%20We%20finally%20propose%20a%20framework%20to%20optimize%20the%20association%2C%20with%20pragmatic%20approaches%20depending%20on%20the%20stage%20of%20the%20disease.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffonc.2021.662236%22%2C%22ISSN%22%3A%222234-943X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22MCWU4QSQ%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-06-16T11%3A46%3A20Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Angeles, Martina Aida, Hélène Leray, Federico Migliorelli, Manon Daix, Alejandra Martinez, and Gwenael Ferron. “Surgical Approach of the Left Upper Quadrant for Ovarian Cancer in 10 Steps.” International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society<\/i> 31, no. 11 (November 2021): 1488–89. https:\/\/doi.org\/10.1136\/ijgc-2021-002963<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Cerapio, Juan-Pablo, Marion Perrier, Camille-Charlotte Balança, Pauline Gravelle, Fréderic Pont, Christel Devaud, Don-Marc Franchini, et al. “Phased Differentiation of Γδ T and T CD8 Tumor-Infiltrating Lymphocytes Revealed by Single-Cell Transcriptomics of Human Cancers.” Oncoimmunology<\/i> 10, no. 1 (2021): 1939518. https:\/\/doi.org\/10.1080\/2162402X.2021.1939518<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Khalifa, Jonathan, Julien Mazieres, Carlos Gomez-Roca, Maha Ayyoub, and Elizabeth Cohen-Jonathan Moyal. “Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?” Frontiers in Oncology<\/i> 11 (2021): 662236. https:\/\/doi.org\/10.3389\/fonc.2021.662236<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n
\n[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2020″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.16″ _module_preset=”default” title_text_color=”#505659″ title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_text_align=”center” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” global_colors_info=”{}”]
\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tFGRJFWV3<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2020<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 39181<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-07c307ec8e8073f0df7b8a28766286a7%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22TZDYZ79F%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Balan%5Cu00e7a%20et%20al.%22%2C%22parsedDate%22%3A%222020-12-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBalan%26%23xE7%3Ba%2C%20Camille-Charlotte%2C%20Anna%20Salvioni%2C%20Clara-Maria%20Scarlata%2C%20Marie%20Michelas%2C%20Carlos%20Martinez-Gomez%2C%20Carlos%20Gomez-Roca%2C%20Victor%20Sarradin%2C%20et%20al.%20%26%23x201C%3BPD-1%20Blockade%20Restores%20Helper%20Activity%20of%20Tumor-Infiltrating%20Exhausted%20PD-1hiCD39%2B%20CD4%20T%20Cells.%26%23x201D%3B%20%3Ci%3EJCI%20Insight%3C%5C%2Fi%3E%2C%20December%2017%2C%202020.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2Fjci.insight.142513%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2Fjci.insight.142513%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22PD-1%20blockade%20restores%20helper%20activity%20of%20tumor-infiltrating%20exhausted%20PD-1hiCD39%2B%20CD4%20T%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille-Charlotte%22%2C%22lastName%22%3A%22Balan%5Cu00e7a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Salvioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara-Maria%22%2C%22lastName%22%3A%22Scarlata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Michelas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Martinez-Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Gomez-Roca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Sarradin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Tosolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carine%22%2C%22lastName%22%3A%22Valle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Pont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gw%5Cu00e9na%5Cu00ebl%22%2C%22lastName%22%3A%22Ferron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Gladieff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Vergez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agn%5Cu00e8s%22%2C%22lastName%22%3A%22Dupret-Bories%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Mery%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Rochaix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Jacques%22%2C%22lastName%22%3A%22Fourni%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Delord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christel%22%2C%22lastName%22%3A%22Devaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-12-17%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1172%5C%2Fjci.insight.142513%22%2C%22ISSN%22%3A%222379-3708%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Finsight.jci.org%5C%2Farticles%5C%2Fview%5C%2F142513%22%2C%22collections%22%3A%5B%22QS3I9WIA%22%2C%22WVCHCN8C%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A22%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22UEG3I9S7%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Montfort%20et%20al.%22%2C%22parsedDate%22%3A%222020-12-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMontfort%2C%20Anne%2C%20Thomas%20Filleron%2C%20Mathieu%20Virazels%2C%20Carine%20Dufau%2C%20Jean%20Milh%26%23xE8%3Bs%2C%20C%26%23xE9%3Bcile%20Pages%2C%20Pascale%20Olivier%2C%20et%20al.%20%26%23x201C%3BCombining%20Nivolumab%20and%20Ipilimumab%20with%20Infliximab%20or%20Certolizumab%20in%20Patients%20with%20Advanced%20Melanoma%3A%20First%20Results%20of%20a%20Phase%201b%20Clinical%20Trial.%26%23x201D%3B%20%3Ci%3EClinical%20Cancer%20Research%3C%5C%2Fi%3E%2C%20December%203%2C%202020%2C%20clincanres.3449.2020.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1078-0432.CCR-20-3449%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1078-0432.CCR-20-3449%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Combining%20nivolumab%20and%20ipilimumab%20with%20infliximab%20or%20certolizumab%20in%20patients%20with%20advanced%20melanoma%3A%20first%20results%20of%20a%20phase%201b%20clinical%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Montfort%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Filleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathieu%22%2C%22lastName%22%3A%22Virazels%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carine%22%2C%22lastName%22%3A%22Dufau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%22%2C%22lastName%22%3A%22Milh%5Cu00e8s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9cile%22%2C%22lastName%22%3A%22Pages%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascale%22%2C%22lastName%22%3A%22Olivier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muriel%22%2C%22lastName%22%3A%22Mounier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Lusque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Brayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Delord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Andrieu-Abadie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Levade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Celine%22%2C%22lastName%22%3A%22Colacios%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22S%5Cu00e9gui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Meyer%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-12-03%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1158%5C%2F1078-0432.CCR-20-3449%22%2C%22ISSN%22%3A%221078-0432%2C%201557-3265%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fclincancerres.aacrjournals.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1158%5C%2F1078-0432.CCR-20-3449%22%2C%22collections%22%3A%5B%22KC3WFBJR%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A22%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22JKYPDFWE%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Weulersse%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-13%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWeulersse%2C%20Marianne%2C%20Assia%20Asrir%2C%20Andrea%20C.%20Pichler%2C%20Lea%20Lemaitre%2C%20Matthias%20Braun%2C%20Nadege%20Carrie%2C%20Marie-Veronique%20Joubert%2C%20et%20al.%20%26%23x201C%3BEomes-Dependent%20Loss%20of%20the%20Co-Activating%20Receptor%20CD226%20Restrains%20CD8%28%2B%29%20T%20Cell%20Anti-Tumor%20Functions%20and%20Limits%20the%20Efficacy%20of%20Cancer%20Immunotherapy.%26%23x201D%3B%20%3Ci%3EImmunity%3C%5C%2Fi%3E%2053%2C%20no.%204%20%28October%2013%2C%202020%29%3A%20824-839.e10.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.immuni.2020.09.006%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.immuni.2020.09.006%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Eomes-Dependent%20Loss%20of%20the%20Co-activating%20Receptor%20CD226%20Restrains%20CD8%28%2B%29%20T%20Cell%20Anti-tumor%20Functions%20and%20Limits%20the%20Efficacy%20of%20Cancer%20Immunotherapy.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marianne%22%2C%22lastName%22%3A%22Weulersse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Assia%22%2C%22lastName%22%3A%22Asrir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20C.%22%2C%22lastName%22%3A%22Pichler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lea%22%2C%22lastName%22%3A%22Lemaitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Braun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadege%22%2C%22lastName%22%3A%22Carrie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Veronique%22%2C%22lastName%22%3A%22Joubert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Le%20Moine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Do%20Souto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Gaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Indrajit%22%2C%22lastName%22%3A%22Das%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Brauns%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%20M.%22%2C%22lastName%22%3A%22Scarlata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Morandi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashmitha%22%2C%22lastName%22%3A%22Sundarrajan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marine%22%2C%22lastName%22%3A%22Cuisinier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laure%22%2C%22lastName%22%3A%22Buisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Maheo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sahar%22%2C%22lastName%22%3A%22Kassem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arantxa%22%2C%22lastName%22%3A%22Agesta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Peres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Els%22%2C%22lastName%22%3A%22Verhoeyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Mazieres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loic%22%2C%22lastName%22%3A%22Dupre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Gossye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vera%22%2C%22lastName%22%3A%22Pancaldi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Guillerey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20S.%22%2C%22lastName%22%3A%22Dejean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdelhadi%22%2C%22lastName%22%3A%22Saoudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanislas%22%2C%22lastName%22%3A%22Goriely%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Herve%22%2C%22lastName%22%3A%22Avet-Loiseau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tobias%22%2C%22lastName%22%3A%22Bald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Smyth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ludovic%22%2C%22lastName%22%3A%22Martinet%22%7D%5D%2C%22abstractNote%22%3A%22CD8%28%2B%29%20T%20cells%20within%20the%20tumor%20microenvironment%20%28TME%29%20are%20exposed%20to%20various%20signals%20that%20ultimately%20determine%20functional%20outcomes.%20Here%2C%20we%20examined%20the%20role%20of%20the%20co-activating%20receptor%20CD226%20%28DNAM-1%29%20in%20CD8%28%2B%29%20T%20cell%20function.%20The%20absence%20of%20CD226%20expression%20identified%20a%20subset%20of%20dysfunctional%20CD8%28%2B%29%20T%20cells%20present%20in%20peripheral%20blood%20of%20healthy%20individuals.%20These%20cells%20exhibited%20reduced%20LFA-1%20activation%2C%20altered%20TCR%20signaling%2C%20and%20a%20distinct%20transcriptomic%20program%20upon%20stimulation.%20CD226%28neg%29%20CD8%28%2B%29%20T%20cells%20accumulated%20in%20human%20and%20mouse%20tumors%20of%20diverse%20origin%20through%20an%20antigen-specific%20mechanism%20involving%20the%20transcriptional%20regulator%20Eomesodermin%20%28Eomes%29.%20Despite%20similar%20expression%20of%20co-inhibitory%20receptors%2C%20CD8%28%2B%29%20tumor-infiltrating%20lymphocyte%20failed%20to%20respond%20to%20anti-PD-1%20in%20the%20absence%20of%20CD226.%20Immune%20checkpoint%20blockade%20efficacy%20was%20hampered%20in%20Cd226%28-%5C%2F-%29%20mice.%20Anti-CD137%20%284-1BB%29%20agonists%20also%20stimulated%20Eomes-dependent%20CD226%20loss%20that%20limited%20the%20anti-tumor%20efficacy%20of%20this%20treatment.%20Thus%2C%20CD226%20loss%20restrains%20CD8%28%2B%29%20T%20cell%20function%20and%20limits%20the%20efficacy%20of%20cancer%20immunotherapy.%22%2C%22date%22%3A%222020%20Oct%2013%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.immuni.2020.09.006%22%2C%22ISSN%22%3A%221097-4180%201074-7613%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%223U3NWA3K%22%2C%226FNA338P%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-06-16T14%3A03%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22DPIIILDF%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fluckiger%20et%20al.%22%2C%22parsedDate%22%3A%222020-08-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFluckiger%2C%20Aur%26%23xE9%3Blie%2C%20Romain%20Daill%26%23xE8%3Bre%2C%20Mohamed%20Sassi%2C%20Barbara%20Susanne%20Sixt%2C%20Peng%20Liu%2C%20Friedemann%20Loos%2C%20Corentin%20Richard%2C%20et%20al.%20%26%23x201C%3BCross-Reactivity%20between%20Tumor%20MHC%20Class%20I-Restricted%20Antigens%20and%20an%20Enterococcal%20Bacteriophage.%26%23x201D%3B%20%3Ci%3EScience%20%28New%20York%2C%20N.Y.%29%3C%5C%2Fi%3E%20369%2C%20no.%206506%20%28August%2021%2C%202020%29%3A%20936%26%23x2013%3B42.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fscience.aax0701%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fscience.aax0701%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cross-reactivity%20between%20tumor%20MHC%20class%20I-restricted%20antigens%20and%20an%20enterococcal%20bacteriophage%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Fluckiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Daill%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohamed%22%2C%22lastName%22%3A%22Sassi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%20Susanne%22%2C%22lastName%22%3A%22Sixt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Loos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corentin%22%2C%22lastName%22%3A%22Richard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Rabu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryam%20Tidjani%22%2C%22lastName%22%3A%22Alou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Ga%5Cu00eblle%22%2C%22lastName%22%3A%22Goubet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabien%22%2C%22lastName%22%3A%22Lemaitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gladys%22%2C%22lastName%22%3A%22Ferrere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Derosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connie%20P.%20M.%22%2C%22lastName%22%3A%22Duong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meriem%22%2C%22lastName%22%3A%22Messaoudene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22Gagn%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Joubert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luisa%22%2C%22lastName%22%3A%22De%20Sordi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Debarbieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Simon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara-Maria%22%2C%22lastName%22%3A%22Scarlata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%22%2C%22lastName%22%3A%22Palermo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesco%22%2C%22lastName%22%3A%22Facciolo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Boidot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Wheeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivo%20Gomperts%22%2C%22lastName%22%3A%22Boneca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zsofia%22%2C%22lastName%22%3A%22Sztupinszki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krisztian%22%2C%22lastName%22%3A%22Papp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Istvan%22%2C%22lastName%22%3A%22Csabai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edoardo%22%2C%22lastName%22%3A%22Pasolli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Segata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Lopez-Otin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Szallasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrice%22%2C%22lastName%22%3A%22Andre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valerio%22%2C%22lastName%22%3A%22Iebba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valentin%22%2C%22lastName%22%3A%22Quiniou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Klatzmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22Boukhalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saber%22%2C%22lastName%22%3A%22Khelaifia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Raoult%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Albiges%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Escudier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Eggermont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fathia%22%2C%22lastName%22%3A%22Mami-Chouaib%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paola%22%2C%22lastName%22%3A%22Nistico%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Ghiringhelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bertrand%22%2C%22lastName%22%3A%22Routy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Labarri%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Cattoir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guido%22%2C%22lastName%22%3A%22Kroemer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Zitvogel%22%7D%5D%2C%22abstractNote%22%3A%22Intestinal%20microbiota%20have%20been%20proposed%20to%20induce%20commensal-specific%20memory%20T%20cells%20that%20cross-react%20with%20tumor-associated%20antigens.%20We%20identified%20major%20histocompatibility%20complex%20%28MHC%29%20class%20I-binding%20epitopes%20in%20the%20tail%20length%20tape%20measure%20protein%20%28TMP%29%20of%20a%20prophage%20found%20in%20the%20genome%20of%20the%20bacteriophage%20Enterococcus%20hirae%20Mice%20bearing%20E.%20hirae%20harboring%20this%20prophage%20mounted%20a%20TMP-specific%20H-2Kb-restricted%20CD8%2B%20T%20lymphocyte%20response%20upon%20immunotherapy%20with%20cyclophosphamide%20or%20anti-PD-1%20antibodies.%20Administration%20of%20bacterial%20strains%20engineered%20to%20express%20the%20TMP%20epitope%20improved%20immunotherapy%20in%20mice.%20In%20renal%20and%20lung%20cancer%20patients%2C%20the%20presence%20of%20the%20enterococcal%20prophage%20in%20stools%20and%20expression%20of%20a%20TMP-cross-reactive%20antigen%20by%20tumors%20correlated%20with%20long-term%20benefit%20of%20PD-1%20blockade%20therapy.%20In%20melanoma%20patients%2C%20T%20cell%20clones%20recognizing%20naturally%20processed%20cancer%20antigens%20that%20are%20cross-reactive%20with%20microbial%20peptides%20were%20detected.%22%2C%22date%22%3A%22Aug%2021%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.aax0701%22%2C%22ISSN%22%3A%221095-9203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A21%3A14Z%22%7D%7D%2C%7B%22key%22%3A%2274Y4L2MB%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Trimaglio%20et%20al.%22%2C%22parsedDate%22%3A%222020-07-12%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ETrimaglio%2C%20Giulia%2C%20Anne-Fran%26%23xE7%3Boise%20Tilkin-Mariam%26%23xE9%3B%2C%20Virginie%20Feliu%2C%20Fran%26%23xE7%3Boise%20Lauz%26%23xE9%3Bral-Vizcaino%2C%20Marie%20Tosolini%2C%20Carine%20Valle%2C%20Maha%20Ayyoub%2C%20et%20al.%20%26%23x201C%3BColon-Specific%20Immune%20Microenvironment%20Regulates%20Cancer%20Progression%20versus%20Rejection.%26%23x201D%3B%20%3Ci%3EOncoimmunology%3C%5C%2Fi%3E%209%2C%20no.%201%20%28July%2012%2C%202020%29%3A%201790125.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F2162402X.2020.1790125%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F2162402X.2020.1790125%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Colon-specific%20immune%20microenvironment%20regulates%20cancer%20progression%20versus%20rejection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giulia%22%2C%22lastName%22%3A%22Trimaglio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Tilkin-Mariam%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virginie%22%2C%22lastName%22%3A%22Feliu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Lauz%5Cu00e9ral-Vizcaino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Tosolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carine%22%2C%22lastName%22%3A%22Valle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Neyrolles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Vergnolle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoann%22%2C%22lastName%22%3A%22Rombouts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christel%22%2C%22lastName%22%3A%22Devaud%22%7D%5D%2C%22abstractNote%22%3A%22Immunotherapies%20have%20achieved%20clinical%20benefit%20in%20many%20types%20of%20cancer%20but%20remain%20limited%20to%20a%20subset%20of%20patients%20in%20colorectal%20cancer%20%28CRC%29.%20Resistance%20to%20immunotherapy%20can%20be%20attributed%20in%20part%20to%20tissue-specific%20factors%20constraining%20antitumor%20immunity.%20Thus%2C%20a%20better%20understanding%20of%20how%20the%20colon%20microenvironment%20shapes%20the%20immune%20response%20to%20CRC%20is%20needed%20to%20identify%20mechanisms%20of%20resistance%20to%20immunotherapies%20and%20guide%20the%20development%20of%20novel%20therapeutics.%20In%20an%20orthotopic%20mouse%20model%20of%20MC38-CRC%2C%20tumor%20progression%20was%20monitored%20by%20bioluminescence%20imaging%20and%20the%20immune%20signatures%20were%20assessed%20at%20a%20transcriptional%20level%20using%20NanoString%20and%20at%20a%20cellular%20level%20by%20flow%20cytometry.%20Despite%20initial%20tumor%20growth%20in%20all%20mice%2C%20only%2025%25%20to%2035%25%20of%20mice%20developed%20a%20progressive%20lethal%20CRC%20while%20the%20remaining%20animals%20spontaneously%20rejected%20their%20solid%20tumor.%20No%20tumor%20rejection%20was%20observed%20in%20the%20absence%20of%20adaptive%20immunity%2C%20nor%20when%20MC38%20cells%20were%20injected%20in%20non-orthotopic%20locations%2C%20subcutaneously%20or%20into%20the%20liver.%20We%20observed%20that%20progressive%20CRC%20tumors%20exhibited%20a%20protumor%20immune%20response%2C%20characterized%20by%20a%20regulatory%20T-lymphocyte%20pattern%2C%20discernible%20shortly%20post-tumor%20implantation%2C%20as%20well%20as%20suppressive%20myeloid%20cells.%20In%20contrast%2C%20tumor-rejecting%20mice%20presented%20an%20early%20inflammatory%20response%20and%20an%20antitumor%20microenvironment%20enriched%20in%20CD8%2B%20T%20cells.%20Taken%20together%2C%20our%20data%20demonstrate%20the%20role%20of%20the%20colon%20microenvironment%20in%20regulating%20the%20balance%20between%20anti%20or%20protumor%20immune%20responses.%20While%20emphasizing%20the%20relevance%20of%20the%20CRC%20orthotopic%20model%2C%20they%20set%20the%20basis%20for%20exploring%20the%20impact%20of%20the%20identified%20signatures%20in%20colon%20cancer%20response%20to%20immunotherapy.%22%2C%22date%22%3A%222020-07-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F2162402X.2020.1790125%22%2C%22ISSN%22%3A%222162-4011%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-10-12T10%3A50%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22JGVYC2VA%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martinez%20et%20al.%22%2C%22parsedDate%22%3A%222020-07-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMartinez%2C%20Alejandra%2C%20Jean-Pierre%20Delord%2C%20Maha%20Ayyoub%2C%20and%20Christel%20Devaud.%20%26%23x201C%3BPreclinical%20and%20Clinical%20Immunotherapeutic%20Strategies%20in%20Epithelial%20Ovarian%20Cancer.%26%23x201D%3B%20%3Ci%3ECancers%3C%5C%2Fi%3E%2012%2C%20no.%207%20%28July%202%2C%202020%29%3A%201761.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers12071761%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers12071761%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preclinical%20and%20Clinical%20Immunotherapeutic%20Strategies%20in%20Epithelial%20Ovarian%20Cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Delord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christel%22%2C%22lastName%22%3A%22Devaud%22%7D%5D%2C%22abstractNote%22%3A%22In%20the%20past%2020%20years%2C%20the%20immune%20system%20has%20increasingly%20been%20recognized%20as%20a%20major%20player%20in%20tumor%20cell%20control%2C%20leading%20to%20considerable%20advances%20in%20cancer%20treatment.%20While%20promising%20with%20regards%20to%20melanoma%2C%20renal%20cancer%20and%20non-small%20cell%20lung%20cancer%2C%20immunotherapy%20provides%2C%20for%20the%20time%20being%2C%20limited%20success%20in%20other%20cancers%2C%20including%20ovarian%20cancer%2C%20potentially%20due%20to%20insufficient%20immunogenicity%20or%20to%20a%20particularly%20immunosuppressive%20microenvironment.%20In%20this%20review%2C%20we%20provide%20a%20global%20description%20of%20the%20immune%20context%20of%20ovarian%20cancer%2C%20in%20particular%20epithelial%20ovarian%20cancer%20%28EOC%29.%20We%20describe%20the%20adaptive%20and%20innate%20components%20involved%20in%20the%20EOC%20immune%20response%2C%20including%20infiltrating%20tumor-specific%20T%20lymphocytes%2C%20B%20lymphocytes%2C%20and%20natural%20killer%20and%20myeloid%20cells.%20In%20addition%2C%20we%20highlight%20the%20rationale%20behind%20the%20use%20of%20EOC%20preclinical%20mouse%20models%20to%20assess%20resistance%20to%20immunotherapy%2C%20and%20we%20summarize%20the%20main%20preclinical%20studies%20that%20yielded%20anti-EOC%20immunotherapeutic%20strategies.%20Finally%2C%20we%20focus%20on%20major%20published%20or%20ongoing%20immunotherapy%20clinical%20trials%20concerning%20EOC.%22%2C%22date%22%3A%222020-07-02%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fcancers12071761%22%2C%22ISSN%22%3A%222072-6694%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2072-6694%5C%2F12%5C%2F7%5C%2F1761%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A21%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22LJQSY8VX%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Balan%5Cu00e7a%20et%20al.%22%2C%22parsedDate%22%3A%222020-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBalan%26%23xE7%3Ba%2C%20Camille-Charlotte%2C%20Clara-Maria%20Scarlata%2C%20Marie%20Michelas%2C%20Christel%20Devaud%2C%20Victor%20Sarradin%2C%20Camille%20Franchet%2C%20Carlos%20Martinez%20Gomez%2C%20et%20al.%20%26%23x201C%3BDual%20Relief%20of%20T-Lymphocyte%20Proliferation%20and%20Effector%20Function%20Underlies%20Response%20to%20PD-1%20Blockade%20in%20Epithelial%20Malignancies.%26%23x201D%3B%20%3Ci%3ECancer%20Immunology%20Research%3C%5C%2Fi%3E%208%2C%20no.%207%20%28July%202020%29%3A%20869%26%23x2013%3B82.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2326-6066.CIR-19-0855%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2326-6066.CIR-19-0855%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dual%20Relief%20of%20T-lymphocyte%20Proliferation%20and%20Effector%20Function%20Underlies%20Response%20to%20PD-1%20Blockade%20in%20Epithelial%20Malignancies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille-Charlotte%22%2C%22lastName%22%3A%22Balan%5Cu00e7a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara-Maria%22%2C%22lastName%22%3A%22Scarlata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Michelas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christel%22%2C%22lastName%22%3A%22Devaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Sarradin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Franchet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Martinez%20Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Gomez-Roca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Tosolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Heaugwane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Lauz%5Cu00e9ral-Vizcaino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucile%22%2C%22lastName%22%3A%22Mir-Mesnier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virginie%22%2C%22lastName%22%3A%22F%5Cu00e9liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carine%22%2C%22lastName%22%3A%22Valle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Pont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gw%5Cu00e9na%5Cu00ebl%22%2C%22lastName%22%3A%22Ferron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Gladieff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Motton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yann%22%2C%22lastName%22%3A%22Tanguy%20Le%20Gac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agn%5Cu00e8s%22%2C%22lastName%22%3A%22Dupret-Bories%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Sarini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Vairel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Illac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aurore%22%2C%22lastName%22%3A%22Siegfried-Vergnon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Mery%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Jacques%22%2C%22lastName%22%3A%22Fourni%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Vergez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Delord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Rochaix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%5D%2C%22abstractNote%22%3A%22Although%20understanding%20of%20T-cell%20exhaustion%20is%20widely%20based%20on%20mouse%20models%2C%20its%20analysis%20in%20patients%20with%20cancer%20could%20provide%20clues%20indicating%20tumor%20sensitivity%20to%20immune%20checkpoint%20blockade%20%28ICB%29.%20Data%20suggest%20a%20role%20for%20costimulatory%20pathways%2C%20particularly%20CD28%2C%20in%20exhausted%20T-cell%20responsiveness%20to%20PD-1%5C%2FPD-L1%20blockade.%20Here%2C%20we%20used%20single-cell%20transcriptomic%2C%20phenotypic%2C%20and%20functional%20approaches%20to%20dissect%20the%20relation%20between%20CD8%2B%20T-cell%20exhaustion%2C%20CD28%20costimulation%2C%20and%20tumor%20specificity%20in%20head%20and%20neck%2C%20cervical%2C%20and%20ovarian%20cancers.%20We%20found%20that%20memory%20tumor-specific%20CD8%2B%20T%20cells%2C%20but%20not%20bystander%20cells%2C%20sequentially%20express%20immune%20checkpoints%20once%20they%20infiltrate%20tumors%2C%20leading%2C%20in%20situ%2C%20to%20a%20functionally%20exhausted%20population.%20Exhausted%20T%20cells%20were%20nonetheless%20endowed%20with%20effector%20and%20tumor%20residency%20potential%20but%20exhibited%20loss%20of%20the%20costimulatory%20receptor%20CD28%20in%20comparison%20with%20their%20circulating%20memory%20counterparts.%20Accordingly%2C%20PD-1%20inhibition%20improved%20proliferation%20of%20circulating%20tumor-specific%20CD8%2B%20T%20cells%20and%20reversed%20functional%20exhaustion%20of%20specific%20T%20cells%20at%20tumor%20sites.%20In%20agreement%20with%20their%20tumor%20specificity%2C%20high%20infiltration%20of%20tumors%20by%20exhausted%20cells%20was%20predictive%20of%20response%20to%20therapy%20and%20survival%20in%20ICB-treated%20patients%20with%20head%20and%20neck%20cancer.%20Our%20results%20showed%20that%20PD-1%20blockade-mediated%20proliferation%5C%2Freinvigoration%20of%20circulating%20memory%20T%20cells%20and%20local%20reversion%20of%20exhaustion%20occur%20concurrently%20to%20control%20tumors.%22%2C%22date%22%3A%22Jul%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2326-6066.CIR-19-0855%22%2C%22ISSN%22%3A%222326-6074%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QS3I9WIA%22%2C%22WVCHCN8C%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A21%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22YK5T475M%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pont%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPont%2C%20Fr%26%23xE9%3Bd%26%23xE9%3Bric%2C%20Marie%20Tosolini%2C%20Qing%20Gao%2C%20Marion%20Perrier%2C%20Miguel%20Madrid-Menc%26%23xED%3Ba%2C%20Tse%26%23xA0%3BShun%20Huang%2C%20Pierre%20Neuvial%2C%20Maha%20Ayyoub%2C%20Kristopher%20Nazor%2C%20and%20Jean-Jacques%20Fourni%26%23xE9%3B.%20%26%23x201C%3BSingle-Cell%20Virtual%20Cytometer%20Allows%20User-Friendly%20and%20Versatile%20Analysis%20and%20Visualization%20of%20Multimodal%20Single%20Cell%20RNAseq%20Datasets.%26%23x201D%3B%20%3Ci%3ENAR%20Genomics%20and%20Bioinformatics%3C%5C%2Fi%3E%202%2C%20no.%202%20%28June%201%2C%202020%29%3A%20lqaa025.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fnargab%5C%2Flqaa025%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fnargab%5C%2Flqaa025%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single-Cell%20Virtual%20Cytometer%20allows%20user-friendly%20and%20versatile%20analysis%20and%20visualization%20of%20multimodal%20single%20cell%20RNAseq%20datasets%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Pont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Tosolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qing%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%22%2C%22lastName%22%3A%22Perrier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Madrid-Menc%5Cu00eda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tse%5Cu00a0Shun%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Neuvial%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%22%2C%22lastName%22%3A%22Nazor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Jacques%22%2C%22lastName%22%3A%22Fourni%5Cu00e9%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20%20%20The%20development%20of%20single-cell%20transcriptomic%20technologies%20yields%20large%20datasets%20comprising%20multimodal%20informations%2C%20such%20as%20transcriptomes%20and%20immunophenotypes.%20Despite%20the%20current%20explosion%20of%20methods%20for%20pre-processing%20and%20integrating%20multimodal%20single-cell%20data%2C%20there%20is%20currently%20no%20user-friendly%20software%20to%20display%20easily%20and%20simultaneously%20both%20immunophenotype%20and%20transcriptome-based%20UMAP%5C%2Ft-SNE%20plots%20from%20the%20pre-processed%20data.%20Here%2C%20we%20introduce%20Single-Cell%20Virtual%20Cytometer%2C%20an%20open-source%20software%20for%20flow%20cytometry-like%20visualization%20and%20exploration%20of%20pre-processed%20multi-omics%20single%20cell%20datasets.%20Using%20an%20original%20CITE-seq%20dataset%20of%20PBMC%20from%20an%20healthy%20donor%2C%20we%20illustrate%20its%20use%20for%20the%20integrated%20analysis%20of%20transcriptomes%20and%20epitopes%20of%20functional%20maturation%20in%20human%20peripheral%20T%20lymphocytes.%20So%20this%20free%20and%20open-source%20algorithm%20constitutes%20a%20unique%20resource%20for%20biologists%20seeking%20for%20a%20user-friendly%20analytic%20tool%20for%20multimodal%20single%20cell%20datasets.%22%2C%22date%22%3A%222020-06-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1093%5C%2Fnargab%5C%2Flqaa025%22%2C%22ISSN%22%3A%222631-9268%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fnargab%5C%2Farticle%5C%2Fdoi%5C%2F10.1093%5C%2Fnargab%5C%2Flqaa025%5C%2F5822687%22%2C%22collections%22%3A%5B%22QS3I9WIA%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A22%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22P226WC3R%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Prat%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPrat%2C%20M%26%23xE9%3Blissa%2C%20Augustin%20Le%20Naour%2C%20Kimberley%20Coulson%2C%20Fanny%20Lem%26%23xE9%3Be%2C%20H%26%23xE9%3Bl%26%23xE8%3Bne%20Leray%2C%20Godefroy%20Jacquemin%2C%20Mouna%20Chirine%20Rahabi%2C%20et%20al.%20%26%23x201C%3BCirculating%20CD14%20%3Csup%3Ehigh%3C%5C%2Fsup%3E%20CD16%20%3Csup%3Elow%3C%5C%2Fsup%3E%20Intermediate%20Blood%20Monocytes%20as%20a%20Biomarker%20of%20Ascites%20Immune%20Status%20and%20Ovarian%20Cancer%20Progression.%26%23x201D%3B%20%3Ci%3EJournal%20for%20ImmunoTherapy%20of%20Cancer%3C%5C%2Fi%3E%208%2C%20no.%201%20%282020%29%3A%20e000472.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fjitc-2019-000472%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fjitc-2019-000472%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Circulating%20CD14%20%3Csup%3Ehigh%3C%5C%2Fsup%3E%20CD16%20%3Csup%3Elow%3C%5C%2Fsup%3E%20intermediate%20blood%20monocytes%20as%20a%20biomarker%20of%20ascites%20immune%20status%20and%20ovarian%20cancer%20progression%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%5Cu00e9lissa%22%2C%22lastName%22%3A%22Prat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Augustin%22%2C%22lastName%22%3A%22Le%20Naour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberley%22%2C%22lastName%22%3A%22Coulson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Lem%5Cu00e9e%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Leray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Godefroy%22%2C%22lastName%22%3A%22Jacquemin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mouna%20Chirine%22%2C%22lastName%22%3A%22Rahabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%5Cu00e9a%22%2C%22lastName%22%3A%22Lemaitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Authier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwena%5Cu00ebl%22%2C%22lastName%22%3A%22Ferron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Marc%22%2C%22lastName%22%3A%22Barret%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Delord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Gladieff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Tabah-Fisch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Prost%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bettina%22%2C%22lastName%22%3A%22Couderc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agn%5Cu00e8s%22%2C%22lastName%22%3A%22Coste%22%7D%5D%2C%22abstractNote%22%3A%22Background%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Besides%20the%20interest%20of%20an%20early%20detection%20of%20ovarian%20cancer%2C%20there%20is%20an%20urgent%20need%20for%20new%20predictive%20and%20prognostic%20biomarkers%20of%20tumor%20development%20and%20cancer%20treatment.%20In%20healthy%20patients%2C%20circulating%20blood%20monocytes%20are%20typically%20subdivided%20into%20classical%20%2885%25%29%2C%20intermediate%20%285%25%29%20and%20non-classical%20%2810%25%29%20populations.%20Although%20these%20circulating%20monocyte%20subsets%20have%20been%20suggested%20as%20biomarkers%20in%20several%20diseases%2C%20few%20studies%20have%20investigate%20their%20potential%20as%20a%20predictive%20signature%20for%20tumor%20immune%20status%2Ctumor%20growth%20and%20treatment%20adaptation.%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20In%20this%20study%2C%20we%20used%20a%20homogeneous%20cohort%20of%2028%20chemotherapy-na%5Cu00efve%20patients%20with%20ovarian%20cancer%20to%20evaluate%20monocyte%20subsets%20as%20biomarkers%20of%20the%20ascites%20immunological%20status.%20We%20evaluated%20the%20correlations%20between%20circulating%20monocyte%20subsets%20and%20immune%20cells%20and%20tumor%20burden%20in%20peritoneal%20ascites.%20Moreover%2C%20to%20validate%20the%20use%20of%20circulating%20monocyte%20subsets%20tofollow%20tumor%20progression%20and%20treatment%20response%2C%20we%20characterized%20blood%20monocytes%20from%20ovarian%20cancer%20patients%20included%20in%20a%20phase%201%20clinical%20trial%20at%20baseline%20and%20following%20murlentamab%20treatment.%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20demonstrate%20here%20a%20robust%20expansion%20of%20the%20intermediate%20blood%20monocytes%20%28IBMs%29%20in%20ovarian%20cancer%20patients.%20We%20establish%20a%20significant%20positive%20correlation%20between%20IBM%20percentage%20and%20tumor%5Cu2013associate%20macrophages%20with%20a%20CCR2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20high%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5C%2FCD163%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20high%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5C%2FCD206%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20high%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5C%2FCD86%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20low%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20profile.%20Moreover%2C%20IBM%20expansion%20is%20associated%20with%20a%20decreased%20effector%5C%2Fregulatory%20T-cell%20ratio%20in%20ascites%20and%20with%20the%20presence%20of%20soluble%20immunosuppressive%20mediators.%20We%20also%20establish%20that%20IBM%20proportion%20positively%20correlates%20with%20the%20peritoneum%20tumor%20burden.%20Finally%2C%20the%20study%20of%20IBMs%20in%20patients%20with%20ovarian%20cancer%20under%20immunotherapy%20during%20the%20phase%20clinical%20trial%20supports%20IBMs%20to%20follow%20the%20evolution%20of%20tumor%20development%20and%20the%20treatment%20adaptation.%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusions%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20This%20study%2C%20which%20links%20IBM%20level%20with%20immunosuppression%20and%20tumor%20burden%20in%20peritoneum%2C%20identifies%20IBMs%20as%20apotential%20predictive%20signature%20of%20ascites%20immune%20status%20and%20as%20a%20biomarker%20ofovarian%20cancer%20development%20and%20treatment%20response.%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Trial%20registration%20number%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20EudraCT%3A%202015-004252-22%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20NCT02978755%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20.%22%2C%22date%22%3A%2206%5C%2F2020%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fjitc-2019-000472%22%2C%22ISSN%22%3A%222051-1426%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjitc.bmj.com%5C%2Flookup%5C%2Fdoi%5C%2F10.1136%5C%2Fjitc-2019-000472%22%2C%22collections%22%3A%5B%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A21%3A22Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Balança, Camille-Charlotte, Anna Salvioni, Clara-Maria Scarlata, Marie Michelas, Carlos Martinez-Gomez, Carlos Gomez-Roca, Victor Sarradin, et al. “PD-1 Blockade Restores Helper Activity of Tumor-Infiltrating Exhausted PD-1hiCD39+ CD4 T Cells.” JCI Insight<\/i>, December 17, 2020. https:\/\/doi.org\/10.1172\/jci.insight.142513<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Montfort, Anne, Thomas Filleron, Mathieu Virazels, Carine Dufau, Jean Milhès, Cécile Pages, Pascale Olivier, et al. “Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase 1b Clinical Trial.” Clinical Cancer Research<\/i>, December 3, 2020, clincanres.3449.2020. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3449<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Weulersse, Marianne, Assia Asrir, Andrea C. Pichler, Lea Lemaitre, Matthias Braun, Nadege Carrie, Marie-Veronique Joubert, et al. “Eomes-Dependent Loss of the Co-Activating Receptor CD226 Restrains CD8(+) T Cell Anti-Tumor Functions and Limits the Efficacy of Cancer Immunotherapy.” Immunity<\/i> 53, no. 4 (October 13, 2020): 824-839.e10. https:\/\/doi.org\/10.1016\/j.immuni.2020.09.006<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Fluckiger, Aurélie, Romain Daillère, Mohamed Sassi, Barbara Susanne Sixt, Peng Liu, Friedemann Loos, Corentin Richard, et al. “Cross-Reactivity between Tumor MHC Class I-Restricted Antigens and an Enterococcal Bacteriophage.” Science (New York, N.Y.)<\/i> 369, no. 6506 (August 21, 2020): 936–42. https:\/\/doi.org\/10.1126\/science.aax0701<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Trimaglio, Giulia, Anne-Françoise Tilkin-Mariamé, Virginie Feliu, Françoise Lauzéral-Vizcaino, Marie Tosolini, Carine Valle, Maha Ayyoub, et al. “Colon-Specific Immune Microenvironment Regulates Cancer Progression versus Rejection.” Oncoimmunology<\/i> 9, no. 1 (July 12, 2020): 1790125. https:\/\/doi.org\/10.1080\/2162402X.2020.1790125<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Martinez, Alejandra, Jean-Pierre Delord, Maha Ayyoub, and Christel Devaud. “Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer.” Cancers<\/i> 12, no. 7 (July 2, 2020): 1761. https:\/\/doi.org\/10.3390\/cancers12071761<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Balança, Camille-Charlotte, Clara-Maria Scarlata, Marie Michelas, Christel Devaud, Victor Sarradin, Camille Franchet, Carlos Martinez Gomez, et al. “Dual Relief of T-Lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies.” Cancer Immunology Research<\/i> 8, no. 7 (July 2020): 869–82. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0855<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Pont, Frédéric, Marie Tosolini, Qing Gao, Marion Perrier, Miguel Madrid-Mencía, Tse Shun Huang, Pierre Neuvial, Maha Ayyoub, Kristopher Nazor, and Jean-Jacques Fournié. “Single-Cell Virtual Cytometer Allows User-Friendly and Versatile Analysis and Visualization of Multimodal Single Cell RNAseq Datasets.” NAR Genomics and Bioinformatics<\/i> 2, no. 2 (June 1, 2020): lqaa025. https:\/\/doi.org\/10.1093\/nargab\/lqaa025<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Prat, Mélissa, Augustin Le Naour, Kimberley Coulson, Fanny Lemée, Hélène Leray, Godefroy Jacquemin, Mouna Chirine Rahabi, et al. “Circulating CD14 high<\/sup> CD16 low<\/sup> Intermediate Blood Monocytes as a Biomarker of Ascites Immune Status and Ovarian Cancer Progression.” Journal for ImmunoTherapy of Cancer<\/i> 8, no. 1 (2020): e000472. https:\/\/doi.org\/10.1136\/jitc-2019-000472<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n
\n[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2019″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.16″ _module_preset=”default” title_text_color=”#505659″ title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_text_align=”center” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” global_colors_info=”{}”]
\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tFGRJFWV3<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2019<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 39181<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-6a86d017dc465e78cdcae451ab306c0b%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22N2Y6QVUW%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Montfort%20et%20al.%22%2C%22parsedDate%22%3A%222019-11-14%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMontfort%2C%20Anne%2C%20Carine%20Dufau%2C%20C%26%23xE9%3Bline%20Colacios%2C%20Nathalie%20Andrieu-Abadie%2C%20Thierry%20Levade%2C%20Thomas%20Filleron%2C%20Jean-Pierre%20Delord%2C%20Maha%20Ayyoub%2C%20Nicolas%20Meyer%2C%20and%20Bruno%20S%26%23xE9%3Bgui.%20%26%23x201C%3BAnti-TNF%2C%20a%20Magic%20Bullet%20in%20Cancer%20Immunotherapy%3F%26%23x201D%3B%20%3Ci%3EJournal%20for%20Immunotherapy%20of%20Cancer%3C%5C%2Fi%3E%207%2C%20no.%201%20%28November%2014%2C%202019%29%3A%20303.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs40425-019-0802-y%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs40425-019-0802-y%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Anti-TNF%2C%20a%20magic%20bullet%20in%20cancer%20immunotherapy%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Montfort%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carine%22%2C%22lastName%22%3A%22Dufau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Colacios%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Andrieu-Abadie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Levade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Filleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Delord%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22S%5Cu00e9gui%22%7D%5D%2C%22abstractNote%22%3A%22Immune%20checkpoint%20blockers%20%28ICB%29%20have%20revolutionized%20cancer%20therapy.%20However%2C%20complete%20response%20is%20observed%20in%20a%20minority%20of%20patients%20and%20most%20patients%20develop%20immune-related%20adverse%20events%20%28irAEs%29.%20These%20include%20colitis%2C%20which%20can%20be%20treated%20with%20anti-tumor%20necrosis%20factor%20%28TNF%29%20antibodies%20such%20as%20Infliximab.%20In%20a%20recent%20issue%20of%20the%20Journal%20for%20ImmunoTherapy%20of%20Cancer%2C%20Badran%20et%20al.%20reported%20that%20co-administering%20Infliximab%20together%20with%20ICB%20to%20five%20cancer%20patients%20prevents%20colitis%20recurrence%2C%20with%20four%20of%20them%20exhibiting%20overall%20disease%20stability.%20The%20basis%20for%20this%20treatment%20strategy%20stemmed%20from%20our%20pre-clinical%20demonstration%20that%20TNF%20contributes%20to%20resistance%20to%20anti-PD-1%20therapy.%20In%20agreement%20with%20this%20concept%2C%20we%20have%20shown%20that%20TNF%20blockers%20improve%20the%20anti-tumor%20therapeutic%20activity%20of%20ICB%20in%20mice%20and%20based%20on%20these%20findings%20we%20are%20currently%20evaluating%20the%20combination%20in%20melanoma%20patients%20enrolled%20in%20the%20TICIMEL%20clinical%20trial.%20Herein%2C%20%28i%29%20we%20discuss%20the%20scientific%20rationale%20for%20combining%20anti-TNF%20and%20ICB%20in%20cancer%20patients%2C%20%28ii%29%20comment%20on%20the%20paper%20published%20by%20Badran%20et%20al.%20and%20%28iii%29%20provide%20the%20TICIMEL%20clinical%20trial%20design.%22%2C%22date%22%3A%22Nov%2014%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs40425-019-0802-y%22%2C%22ISSN%22%3A%222051-1426%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22KC3WFBJR%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-04-26T15%3A23%3A45Z%22%7D%7D%2C%7B%22key%22%3A%229NBPDPBB%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Franchini%20et%20al.%22%2C%22parsedDate%22%3A%222019-01-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFranchini%2C%20Don-Marc%2C%20Olivia%20Lanvin%2C%20Marie%20Tosolini%2C%20Emilie%20Patras%20de%20Campaigno%2C%20Anne%20Cammas%2C%20Sarah%20P%26%23xE9%3Bricart%2C%20Clara-Maria%20Scarlata%2C%20et%20al.%20%26%23x201C%3BMicrotubule-Driven%20Stress%20Granule%20Dynamics%20Regulate%20Inhibitory%20Immune%20Checkpoint%20Expression%20in%20T%20Cells.%26%23x201D%3B%20%3Ci%3ECell%20Reports%3C%5C%2Fi%3E%2026%2C%20no.%201%20%28January%202%2C%202019%29%3A%2094-107.e7.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.celrep.2018.12.014%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.celrep.2018.12.014%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Microtubule-Driven%20Stress%20Granule%20Dynamics%20Regulate%20Inhibitory%20Immune%20Checkpoint%20Expression%20in%20T%20Cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Don-Marc%22%2C%22lastName%22%3A%22Franchini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivia%22%2C%22lastName%22%3A%22Lanvin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Tosolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Patras%20de%20Campaigno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Cammas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22P%5Cu00e9ricart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara-Maria%22%2C%22lastName%22%3A%22Scarlata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morgane%22%2C%22lastName%22%3A%22Lebras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9dric%22%2C%22lastName%22%3A%22Rossi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laetitia%22%2C%22lastName%22%3A%22Ligat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9deric%22%2C%22lastName%22%3A%22Pont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paola%20B.%22%2C%22lastName%22%3A%22Arimondo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Laurent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%22%2C%22lastName%22%3A%22Ayyoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabien%22%2C%22lastName%22%3A%22Despas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryse%22%2C%22lastName%22%3A%22Lapeyre-Mestre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefania%22%2C%22lastName%22%3A%22Millevoi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Jacques%22%2C%22lastName%22%3A%22Fourni%5Cu00e9%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20the%20clinical%20success%20of%20blocking%20inhibitory%20immune%20checkpoint%20receptors%20such%20as%20programmed%20cell%20death-1%20%28PD-1%29%20in%20cancer%2C%20the%20mechanisms%20controlling%20the%20expression%20of%20these%20receptors%20have%20not%20been%20fully%20elucidated.%20Here%2C%20we%20identify%20a%20post-transcriptional%20mechanism%20regulating%20PD-1%20expression%20in%20T%5Cu00a0cells.%20Upon%20activation%2C%20the%20PDCD1%20mRNA%20and%20ribonucleoprotein%20complexes%20coalesce%20into%20stress%20granules%20that%20require%20microtubules%20and%20the%20kinesin%5Cu00a01%20molecular%20motor%20to%20proceed%20to%20translation.%20Hence%2C%20PD-1%20expression%20is%20highly%20sensitive%20to%20microtubule%20or%20stress%20granule%20inhibitors%20targeting%20this%20pathway.%20Evidence%20from%20healthy%20donors%20and%20cancer%20patients%20reveals%20a%20common%20regulation%20for%20the%20translation%20of%20CTLA4%2C%20LAG3%2C%20TIM3%2C%20TIGIT%2C%20and%20BTLA%20but%20not%20of%20the%20stimulatory%20co-receptors%20OX40%2C%20GITR%2C%20and%204-1BB%20mRNAs.%20In%20patients%2C%20disproportionality%20analysis%20of%20immune-related%20adverse%20events%20for%20currently%20used%20microtubule%20drugs%20unveils%20a%20significantly%20higher%20risk%20of%20autoimmunity.%20Our%20findings%20reveal%20a%20fundamental%20mechanism%20of%20immunoregulation%20with%20great%20importance%20in%20cancer%20immunotherapy.%22%2C%22date%22%3A%22Jan%2002%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2018.12.014%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QS3I9WIA%22%2C%22WVCHCN8C%22%2C%22FGRJFWV3%22%5D%2C%22dateModified%22%3A%222021-04-26T15%3A22%3A55Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Montfort, Anne, Carine Dufau, Céline Colacios, Nathalie Andrieu-Abadie, Thierry Levade, Thomas Filleron, Jean-Pierre Delord, Maha Ayyoub, Nicolas Meyer, and Bruno Ségui. “Anti-TNF, a Magic Bullet in Cancer Immunotherapy?” Journal for Immunotherapy of Cancer<\/i> 7, no. 1 (November 14, 2019): 303. https:\/\/doi.org\/10.1186\/s40425-019-0802-y<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Franchini, Don-Marc, Olivia Lanvin, Marie Tosolini, Emilie Patras de Campaigno, Anne Cammas, Sarah Péricart, Clara-Maria Scarlata, et al. “Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells.” Cell Reports<\/i> 26, no. 1 (January 2, 2019): 94-107.e7. https:\/\/doi.org\/10.1016\/j.celrep.2018.12.014<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n
\n[\/et_pb_toggle][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

LES MEMBRES DE L\u2019\u00c9QUIPE<\/strong><\/h2>\n

[\/et_pb_text][et_pb_divider color=”#F19532″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” max_width=”none” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”]

\n
<\/div>\n\n\n
\n
\n
\n
\n
\n
\"\"<\/a><\/div>\n
Y Lan Blanchard<\/a><\/div>\n
Doctorant \/ PhD student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Caroline Fournier<\/a><\/div>\n
Master \/ Master student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Alejandra Martinez<\/a><\/div>\n
Hospitalo-Universitaire \/ University teacher hospital practitioner<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Jean-Pierre Delord<\/a><\/div>\n
Hospitalo-Universitaire \/ University teacher hospital practitioner<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Myriam Maixent<\/a><\/div>\n
Technicien de laboratoire \/ Laboratory Technician<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Carlos Gomez-Roca<\/a><\/div>\n
Clinicien Chercheur \/ Researcher hospital practitioner<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Maha Ayyoub<\/a><\/div>\n
Hospitalo-Universitaire \/ University teacher hospital practitioner<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Fran\u00e7oise Lauzeral-Vizcaino<\/a><\/div>\n
Ing\u00e9nieur de laboratoire \/ laboratory engineer<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Clara-Maria Scarlata<\/a><\/div>\n
Ing\u00e9nieur de laboratoire \/ laboratory engineer<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Anna Salvioni<\/a><\/div>\n
Chercheur Post-Doctorant \/ Post-Doc researcher<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Christel Devaud<\/a><\/div>\n
Chercheur Post-Doctorant \/ Post-Doc researcher<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Victor Sarradin<\/a><\/div>\n
Doctorant \/ PhD student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Giulia Costanza Leonardi<\/a><\/div>\n
Chercheur Post-Doctorant \/ Post-Doc researcher<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Virginie Feliu<\/a><\/div>\n
Ing\u00e9nieur de laboratoire \/ laboratory engineer<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Lise Scandella<\/a><\/div>\n
Technicien de laboratoire \/ Laboratory Technician<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Marie Michelas<\/a><\/div>\n
Ing\u00e9nieur de laboratoire \/ laboratory engineer<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
C\u00e9lia Ramade<\/a><\/div>\n
Doctorant \/ PhD student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Sylvie Giuriato<\/a><\/div>\n
Chercheur statutaire \/ permanent scientist<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
No\u00e9mie Th\u00e9bault<\/a><\/div>\n
Ing\u00e9nieur de laboratoire \/ laboratory engineer<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n <\/div>\n<\/div><\/div>\n\n
<\/div><\/div>\n\n